بایگانی‌ها: دانلود ها

  • دانلود کتاب My What If Year A Memoir

    دانلود کتاب My What If Year A Memoir

    خرید ایبوک My What If Year: A Memoir

    برای دانلود ایبوک My What If Year: A Memoir و خرید کتاب خاطرات سال «چه می‌شد اگر» من بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود کتاب ایمیل می شود.این ایبوک در فرمت Epub به همراه PDF تبدیلی و به زبان انگلیسی ارسال می شود.نسخه الکترونیکی کتاب قابلیت کپی برداری copy و Paste دارد.

    در صورتی که نیاز به پی دی اف هر کتابی از انتشارات Zibby Publishing دارید با گیگاپیپر مکاتبه کنید.

    My What If Year A Memoir


    Alisha Fernandez Miranda (Author)

    Publisher ‏ : ‎ Zibby Publishing; 1st edition (February 7, 2023)

    Language ‏ : ‎ English

    Hardcover ‏ : ‎ 272 pages

    ISBN-13 ‏ : ‎ 979-8985282818

    Send email to download :ایمیل گیگاپیپر دانلود کتاب مقاله پایان نامه

    Price : 5$

    https://www.amazon.com/My-What-If-Year-Memoir/dp/B0BCHYD4XT

    دانلود رایگان کتاب My What If Year A Memoir

    A People Magazine “Best New Book”

    “Hailed as the next Eat, Pray, Love” ―CNN International

    The Perfect Book to Read at the Start of a New Year

    An exuberant, hilarious memoir about a woman who pauses her successful career for a year and explores the “What If” jobs of her dreams.

    On the cusp of turning forty, Alisha Fernandez Miranda has climbed to the peak of personal and professional success, but at a price; she’s overworked and exhausted.

    Bravely, Alisha decides to give herself a break, temporarily pausing her stressful career as the CEO of a high-powered consulting firm. With the tentative blessing of her husband and eight-year-old twins, she leaves her home in London to spend one year exploring the dream jobs of her youth, seeking answers to the question, “What If?”

    What follows is a spirited and hilarious journey for Alisha – and the reader. Contending with her lack of experience (and the onset of a global pandemic), Alisha gofers for two high-profile Broadway productions (and nearly tramples Stephen Sondheim), attempts to master a fitness regimen called Voga (a cross between yoga and “voguing”), feigns confidence while handling multi-million-dollar artwork at Christie’s, and literally sets her shirt on fire while serving rack of lamb in a posh hotel on Scotland’s remote Isle of Skye. Her experiences are at once challenging and humbling, and push the boundaries of what Alisha thought she was physically, mentally, and emotionally capable of. Alisha’s “What If” year reveals that she can achieve success on her own terms by embodying the spirit of the intern: never stop learning, be flexible, and understand that failure is a prerequisite for growth.

    For anyone who’s ever felt stuck in a rut, My What If Year proves that it’s never too late to say yes to second chances and explore the roads untraveled throughout your life.

    Gain access to additional, behind-the-scenes content via QR code with the purchase of My What If Year in any format.

    دانلود ایبوک خاطرات سال «چه می‌شد اگر» من

    «بهترین کتاب جدید» مجله پیپل

    «به عنوان کتاب بعدی بخور، دعا کن، عشق بورز» – سی‌ان‌ان اینترنشنال

    کتابی بی‌نظیر برای خواندن در آغاز سال نو

    خاطراتی پرانرژی و خنده‌دار درباره زنی که به مدت یک سال حرفه موفق خود را متوقف می‌کند و به دنبال شغل‌های «چه می‌شد اگر» رویایی‌اش می‌گردد.

    آلیشا فرناندز میراندا در آستانه چهل سالگی به اوج موفقیت شخصی و حرفه‌ای رسیده است، اما به قیمتی؛ او بیش از حد کار می‌کند و خسته است.

    آلیشا شجاعانه تصمیم می‌گیرد به خودش استراحت بدهد و موقتاً حرفه پراسترس خود را به عنوان مدیرعامل یک شرکت مشاوره قدرتمند متوقف کند. با دعای خیر همسر و دوقلوهای هشت ساله‌اش، خانه‌اش در لندن را ترک می‌کند تا یک سال را صرف کاوش در شغل‌های رویایی دوران جوانی‌اش کند و به دنبال پاسخ به سوال «چه می‌شد اگر؟» باشد.

    آنچه در ادامه می‌آید، سفری پرانرژی و خنده‌دار برای آلیشا – و خواننده – است. آلیشا در مواجهه با کمبود تجربه‌اش (و شروع یک بیماری همه‌گیر جهانی)، در دو نمایش برادوی سطح بالا (و تقریباً استیون ساندهایم را زیر پا له می‌کند)، تلاش می‌کند تا یک رژیم تناسب اندام به نام وگا (ترکیبی از یوگا و «مد روز») را یاد بگیرد، هنگام کار با آثار هنری چند میلیون دلاری در کریستیز وانمود به اعتماد به نفس می‌کند، و هنگام سرو کردن یک تکه گوشت بره در یک هتل مجلل در جزیره دورافتاده اسکای اسکاتلند، پیراهنش را به معنای واقعی کلمه آتش می‌زند. تجربیات او همزمان چالش برانگیز و فروتنانه هستند و مرزهای آنچه آلیشا فکر می‌کرد از نظر جسمی، ذهنی و عاطفی قادر به انجام آن است را جابجا می‌کنند. سال «چه می‌شد اگر» آلیشا نشان می‌دهد که او می‌تواند با تجسم روحیه کارآموز، به روش خودش به موفقیت دست یابد: هرگز از یادگیری دست نکشید، انعطاف‌پذیر باشید و درک کنید که شکست پیش‌نیاز رشد است.

    برای هر کسی که تا به حال احساس کرده در یک روزمرگی گیر افتاده است، «سال چه می‌شد اگر من» ثابت می‌کند که هیچ‌وقت برای گفتن «بله» به فرصت‌های دوباره و کشف جاده‌های نرفته در طول زندگی دیر نیست.

    با خرید «سال چه می‌شد اگر من» در هر قالبی، از طریق کد QR به محتوای اضافی و پشت صحنه دسترسی پیدا کنید.

  • دانلود کتاب Sales Management Essentials You Always Wanted To Know

    دانلود کتاب Sales Management Essentials You Always Wanted To Know

    خرید ایبوک Sales Management Essentials You Always Wanted To Know

    برای دانلود ایبوک Sales Management Essentials You Always Wanted To Know (Self-Learning Management Series) و خرید کتاب اصول مدیریت فروش که همیشه می‌خواستید بدانید (مجموعه مدیریت خودآموز) بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود کتاب ایمیل می شود.این ایبوک در فرمت Epub به همراه PDF تبدیلی و به زبان انگلیسی ارسال می شود.نسخه الکترونیکی کتاب قابلیت کپی برداری copy و Paste دارد.

    در صورتی که نیاز به پی دی اف هر کتابی از انتشارات Vibrant Publishers دارید با گیگاپیپر مکاتبه کنید.

    Sales Management Essentials You Always Wanted To Know (Self-Learning Management Series)


    by Vibrant Publishers (Author), Vishal Desai (Author)

    Publisher ‏ : ‎ Vibrant Publishers; 1st edition (April 8, 2022)
    Publication date ‏ : ‎ April 8, 2022
    Language ‏ : ‎ English

    Send email to download :ایمیل گیگاپیپر دانلود کتاب مقاله پایان نامه

    Price : 5$

    https://us.amazon.com/gp/aw/d/B09V37ZPNP

    دانلود رایگان کتاب Sales Management Essentials You Always Wanted To Know

    Sales Management Essentials is a ready reckoner on sales management fundamentals and their practical applications!

    Sales Management Essentials contains everything you need to know about Sales Management! In this book, you will learn why (and how) sales and marketing are different and the wide range of sales channels you can use to sell your products. If you’ve been focused on only selling your product and not your product concept, this book will teach you how. (Yes, there’s a difference!) Or perhaps you want to conduct sales promotions and require effective sales promotion techniques that will help you succeed.

    This book will help you to:

    • Understand all aspects of sales management functions
    • Learn how to manage the sales channels and sales-force
    • Discover the relationship between sales and marketing
    • Study various selling tools, sales techniques, and sales strategies
    • Explore various sales promotion activities to increase sales
    • Learn channel conflict management and resolution skills

    The book is an ideal pick for young managers, entrepreneurs, and graduate students who wish to acquaint themselves with all the aspects of sales management. It is also an excellent teaching aid for the academic fraternity and industry professionals who teach sales and marketing management courses.

    About the Series
    Sales Management Essentials is part of the Self-Learning Management Series that is designed to help students, professionals and entrepreneurs learn essential management lessons. This series of books has been written by industry experts who have combined their vast work experiences into relevant, concise, and practical handbooks that appeal to learners from all spheres of life.

    دانلود ایبوک اصول مدیریت فروش که همیشه می‌خواستید بدانید (مجموعه مدیریت خودآموز)

    کتاب «ضروریات مدیریت فروش» یک راهنمای آماده برای اصول مدیریت فروش و کاربردهای عملی آنهاست!

    ضروریات مدیریت فروش شامل هر آنچه که باید در مورد مدیریت فروش بدانید، می‌باشد! در این کتاب، خواهید آموخت که چرا (و چگونه) فروش و بازاریابی متفاوت هستند و طیف گسترده‌ای از کانال‌های فروشی که می‌توانید برای فروش محصولات خود استفاده کنید، کدامند. اگر فقط بر فروش محصول خود و نه مفهوم محصول خود تمرکز کرده‌اید، این کتاب به شما نحوه‌ی انجام این کار را آموزش می‌دهد. (بله، تفاوت وجود دارد!) یا شاید می‌خواهید تبلیغات فروش انجام دهید و به تکنیک‌های مؤثر تبلیغات فروش نیاز دارید که به شما در موفقیت کمک کند.

    این کتاب به شما کمک می‌کند تا:

    تمام جنبه‌های وظایف مدیریت فروش را درک کنید

    نحوه‌ی مدیریت کانال‌های فروش و نیروی فروش را بیاموزید

    رابطه‌ی بین فروش و بازاریابی را کشف کنید

    ابزارهای مختلف فروش، تکنیک‌های فروش و استراتژی‌های فروش را مطالعه کنید

    فعالیت‌های مختلف تبلیغات فروش را برای افزایش فروش بررسی کنید

    مهارت‌های مدیریت تعارض کانال و حل اختلاف را بیاموزید

    این کتاب انتخابی ایده‌آل برای مدیران جوان، کارآفرینان و دانشجویان تحصیلات تکمیلی است که مایل به آشنایی با تمام جنبه‌های مدیریت فروش هستند. همچنین این کتاب یک منبع آموزشی عالی برای انجمن‌های دانشگاهی و متخصصان صنعت است که دوره‌های مدیریت فروش و بازاریابی را تدریس می‌کنند.

    درباره این مجموعه

    کتاب «مبانی مدیریت فروش» بخشی از مجموعه خودآموز مدیریت است که برای کمک به دانشجویان، متخصصان و کارآفرینان در یادگیری درس‌های ضروری مدیریت طراحی شده است. این مجموعه کتاب‌ها توسط متخصصان صنعت نوشته شده است که تجربیات کاری گسترده خود را در کتابچه‌های راهنمای مرتبط، مختصر و کاربردی ترکیب کرده‌اند که برای زبان‌آموزان از همه حوزه‌های زندگی جذاب است.

  • دانلود کتاب فارماکوپه اروپا EP خرید ایبوک European Pharmacopoeia 11th Edition

    دانلود کتاب فارماکوپه اروپا EP خرید ایبوک European Pharmacopoeia 11th Edition

    خرید ایبوک European PHARMACOPOEIA فارماکوپه اروپایی یازدهم ویرایش 11.2

    برای دانلود ایبوک European Pharmacopoeia (Ph. Eur.) 11th Edition و خرید و دانلود کتاب فارماکوپه اروپایی یازدهم ویرایش 11.2 بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود کتاب ایمیل می شود.این ایبوک شامل 2 هزار و 849 فایل PDF و به زبان انگلیسی ارسال می شود.

    در صورتی که نیاز به پی دی اف هر کتابی از انتشارات https://www.edqm.eu دارید با گیگاپیپر مکاتبه کنید.

    European Pharmacopoeia (Ph. Eur.) 11th Edition

    Authors: https://www.edqm.eu/en/european-pharmacopoeia-ph.-eur.
    Language: English

    Send email to download :ایمیل گیگاپیپر دانلود کتاب مقاله پایان نامه

    Price : 50$

    دانلود رایگان کتاب The British Pharmacopoeia 2024

     

    The European Pharmacopoeia (Ph. Eur.) is the primary source of official quality standards for medicines and their ingredients in Europe. Ph. Eur. standards provide a scientific basis for the quality control of a product throughout its life cycle, supporting the pharmaceutical industry and healthcare systems.

    As laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in European Union and national pharmaceutical legislation, these standards are legally binding. They become mandatory on the same date in all states parties to the convention.

    قیمت و خرید دانلود کتاب European Pharmacopoeia نسخه جدید 2023

    کتاب فارماکوپه انگلستان رسمی برای معیارها و استانداردهای دارویی در انگلستان است. این کتاب شامل استاندارد ها، معیارها و نحوه های تجزیه و تحلیل برای تعداد زیادی از داروها و مواد دارویی است. این کتاب همچنین شامل توصیه ها، راهنماها و استانداردهای کاربردی برای تولید، توزیع و استفاده از داروها است.

    در مونوگراف‌ها، تعریف، شناسایی، اسی، آلاینده‌ها، آزمایش‌های خاص و نیازمندی‌های اضافی هر دارو ذکر شده است. این موارد به منظور تضمین هویت، قدرت، کیفیت و خلوص محصولات استفاده می‌شوند. در بخش “اجزای مونوگراف”، مشخصات عمومی مربوط به اجزای مختلف مونوگراف‌ها ذکر شده است.

    لیست منوگرافهای موجود در ایبوک فارماکوپه اروپا را در زیر مشاهده کنید :

    
    
    (S)-Lactic acid
    01 General notices
    2,4-Dichlorobenzyl alcohol
    2.1.1. Droppers
    2.1.2. Comparative table of porosity of sintered-glass filters
    2.1.3. Ultraviolet ray lamps for analytical purposes
    2.1.4. Sieves
    2.1.5. Tubes for comparative tests
    2.1.6. Gas detector tubes
    2.1.7. Balances for analytical purposes
    2.2.1. Clarity and degree of opalescence of liquids
    2.2.2. Degree of coloration of liquids
    2.2.3. Potentiometric determination of pH
    2.2.4. Approximate pH of solutions
    2.2.5. Relative density
    2.2.6. Refractive index
    2.2.7. Optical rotation
    2.2.8. Viscosity
    2.2.9. Capillary viscometer method
    2.2.10. Viscosity - Rotating viscometer method
    2.2.11. Distillation range
    2.2.12. Boiling point
    2.2.13. Determination of water by distillation
    2.2.14. Melting point - capillary method
    2.2.15. Melting point - open capillary method
    2.2.16. Melting point - instantaneous method
    2.2.17. Drop point
    2.2.18. Freezing point
    2.2.19. Amperometric titration
    2.2.20. Potentiometric titration
    2.2.21. Fluorimetry
    2.2.22. Atomic emission spectrometry
    2.2.23. Atomic absorption spectrometry
    2.2.24. Absorption spectrophotometry, infrared
    2.2.25. Absorption spectrophotometry, ultraviolet and visible
    2.2.26. Paper chromatography
    2.2.27. Thin-layer chromatography
    2.2.28. Gas chromatography
    2.2.29. Liquid chromatography
    2.2.30. Size-exclusion chromatography
    2.2.31. Electrophoresis
    2.2.32. Loss on drying
    2.2.33. Nuclear magnetic resonance spectrometry
    2.2.34. Thermal analysis
    2.2.35. Osmolality
    2.2.36. Potentiometric determination of ionic concentration using ion-selective electrodes
    2.2.37. X-ray fluorescence spectrometry
    2.2.38. Conductivity
    2.2.39. Molecular mass distribution in dextrans
    2.2.40. Near-infrared spectroscopy
    2.2.41. Circular dichroism
    2.2.42. Density of solids
    2.2.43. Mass spectrometry
    2.2.44. Total organic carbon in water for pharmaceutical use
    2.2.45. Supercritical fluid chromatography
    2.2.46. Chromatographic separation techniques
    2.2.47. Capillary electrophoresis
    2.2.48. Raman spectroscopy
    2.2.49. Falling ball and automatic rolling ball viscometer methods
    2.2.54. Isoelectric focusing
    2.2.55. Peptide mapping
    2.2.56. Amino acid analysis
    2.2.57. Inductively coupled plasma-atomic emission spectrometry
    2.2.58. Inductively coupled plasma-mass spectrometry
    2.2.59. Glycan analysis of glycoproteins
    2.2.61. Characterisation of crystalline solids by microcalorimetry and solution calorimetry
    2.2.63. Direct amperometric and pulsed electrochemical detection
    2.2.64. Peptide identification by nuclear magnetic resonance spectrometry
    2.2.65. Voltametric titration
    2.2.66. Detection and measurement of radioactivity
    2.3.1. Identification reactions of ions and functional groups
    2.3.2. Identification of fatty oils by thin-layer chromatography
    2.3.3. Identification of phenothiazines by thin-layer chromatography
    2.3.4. Odour
    2.4.1. Ammonium
    2.4.2. Arsenic
    2.4.3. Calcium
    2.4.4. Chlorides
    2.4.5. Fluorides
    2.4.6. Magnesium
    2.4.7. Magnesium and alkaline-earth metals
    2.4.8. Heavy metals
    2.4.9. Iron
    2.4.10. Lead in sugars
    2.4.11. Phosphates
    2.4.12. Potassium
    2.4.13. Sulfates
    2.4.14. Sulfated ash
    2.4.15. Nickel in polyols
    2.4.16. Total ash
    2.4.17. Aluminium
    2.4.18. Free formaldehyde
    2.4.19. Alkaline impurities in fatty oils
    2.4.20. Determination of elemental impurities
    2.4.21. Foreign oils in fatty oils by thin-layer chromatography
    2.4.22. Composition of fatty acids by gas chromatography
    2.4.23. Sterols in fatty oils
    2.4.24. Identification and control of residual solvents
    2.4.25. Ethylene oxide and dioxan
    2.4.26. N,N-Dimethylaniline
    2.4.27. Heavy metals in herbal drugs and herbal drug preparations
    2.4.28. 2-Ethylhexanoic acid
    2.4.29. Composition of fatty acids in oils rich in omega-3 acids
    2.4.30. Ethylene glycol and diethylene glycol in ethoxylated substances
    2.4.31. Nickel in hydrogenated vegetable oils
    2.4.32. Total cholesterol in oils rich in omega-3 acids
    2.4.33. Tetrabutylammonium in radiopharmaceutical preparations
    2.5.1. Acid value
    2.5.2. Ester value
    2.5.3. Hydroxyl value
    2.5.4. Iodine value
    2.5.5. Peroxide value
    2.5.6. Saponification value
    2.5.7. Unsaponifiable matter
    2.5.8. Determination of primary aromatic amino-nitrogen
    2.5.9. Determination of nitrogen by sulfuric acid digestion
    2.5.10. Oxygen-flask method
    2.5.11. Complexometric titrations
    2.5.12. Water semi-micro determination
    2.5.13. Aluminium in adsorbed vaccines
    2.5.14. Calcium in adsorbed vaccines
    2.5.15. Phenol in immunosera and vaccines
    2.5.16. Protein in polysaccharide vaccines
    2.5.17. Nucleic acids in polysaccharide vaccines
    2.5.18. Phosphorus in polysaccharide vaccines
    2.5.19. O-Acetyl in polysaccharide vaccines
    2.5.20. Hexosamines in polysaccharide vaccines
    2.5.21. Methylpentoses in polysaccharide vaccines
    2.5.22. Uronic acids in polysaccharide vaccines
    2.5.23. Sialic acid in polysaccharide vaccines
    2.5.24. Carbon dioxide in gases
    2.5.25. Carbon monoxide in gases
    2.5.26. Nitrogen monoxide and nitrogen dioxide in gases
    2.5.27. Oxygen in gases
    2.5.28. Water in gases
    2.5.29. Sulfur dioxide
    2.5.30. Oxidising substances
    2.5.31. Ribose in polysaccharide vaccines
    2.5.32. Water micro determination
    2.5.33. Total protein
    2.5.34. Acetic acid in synthetic peptides
    2.5.35. Nitrous oxide in gases
    2.5.36. Anisidine value
    2.5.37. Methyl, ethyl and isopropyl methanesulfonate in methanesulfonic acid
    2.5.38. Methyl, ethyl and isopropyl methanesulfonate in active substances
    2.5.39. Methanesulfonyl chloride in methanesulfonic acid
    2.5.40. Methyl, ethyl and isopropyl toluenesulfonate in active substances
    2.5.41. Methyl, ethyl and isopropyl benzenesulfonate in active substances
    2.5.42. N-Nitrosamines in active substances
    2.6.1. Sterility
    2.6.2. Mycobacteria
    2.6.7. Mycoplasmas
    2.6.8. Pyrogens
    2.6.10. Histamine
    2.6.11. Depressor substances
    2.6.12. Microbiological examination of non-sterile products microbial enumeration tests
    2.6.13. Microbiological examination of non-sterile products test for specified micro-organisms
    2.6.14. Bacterial endotoxins
    2.6.15. Prekallikrein activator
    2.6.16. Tests for extraneous agents in viral vaccines for human use
    2.6.17. Test for anticomplementary activity of immunoglobulin
    2.6.18. Test for neurovirulence of live virus vaccines
    2.6.20. Anti-A and anti-B haemagglutinins
    2.6.21. Nucleic acid amplification techniques
    2.6.22. Activated coagulation factors
    2.6.26. Test for anti-D antibodies in human immunoglobulin
    2.6.27. Microbiological examination of cell-based preparations
    2.6.30. Monocyte-activation test
    2.6.31. Microbiological examination of herbal medicinal products for oral use and extracts used in their preparation
    2.6.32. Test for bacterial endotoxins using recombinant factor C
    2.6.33. Residual pertussis toxin
    2.6.34. Host-cell protein assays
    2.6.35. Quantification and characterisation of residual host-cell DNA
    2.6.36. Microbiological examination of live biotherapeutic products tests for enumeration of microbial contaminants
    2.6.37. Principles for the detection of extraneous viruses in immunological veterinary medicinal products using culture methods
    2.6.38. Microbiological examination of live biotherapeutic products tests for specified micro-organisms
    2.6.39. Microbiological examination of human tissues
    2.7.1. Immunochemical methods
    2.7.2. Microbiological assay of antibiotics
    2.7.4. Assay of human coagulation factor VIII
    2.7.5. Assay of heparin
    2.7.6. Assay of diphtheria vaccine (adsorbed)
    2.7.7. Assay of pertussis vaccine (whole cell)
    2.7.8. Assay of tetanus vaccine (adsorbed)
    2.7.9. Test for Fc function of immunoglobulin
    2.7.10. Assay of human coagulation factor VII
    2.7.11. Assay of human coagulation factor IX
    2.7.12. Assay of heparin in coagulation factors
    2.7.13. Assay of human anti-D immunoglobulin
    2.7.14. Assay of hepatitis A vaccine
    2.7.15. Assay of hepatitis B vaccine (rDNA)
    2.7.16. Assay of pertussis vaccine (acellular)
    2.7.17. Assay of human antithrombin III
    2.7.18. Assay of human coagulation factor II
    2.7.19. Assay of human coagulation factor X
    2.7.20. In vivo assay of poliomyelitis vaccine (inactivated)
    2.7.21. Assay of human von Willebrand factor
    2.7.22. Assay of human coagulation factor XI
    2.7.23. Numeration of CD34 CD45+ cells in haematopoietic products
    2.7.24. Flow cytometry
    2.7.25. Assay of human plasmin inhibitor
    2.7.26. Cell-based assays for potency determination of TNF-alpha antagonists
    2.7.27. Flocculation value (Lf) of diphtheria and tetanus toxins and toxoids (Ramon assay)
    2.7.28. Colony-forming cell assay for human haematopoietic progenitor cells
    2.7.29. Nucleated cell count and viability
    2.7.30. Assay of human protein C
    2.7.31. Assay of human protein S
    2.7.32. Assay of human α-1-proteinase inhibitor
    2.7.34. Assay of human C1-esterase inhibitor
    2.7.35. Immunonephelometry for vaccine component assay
    2.7.36. Assay of Bet v 1 allergen
    2.8.1. Ash insoluble in hydrochloric acid
    2.8.2. Foreign matter
    2.8.3. Stomata and stomatal index
    2.8.4. Swelling index
    2.8.5. Water in essential oils
    2.8.6. Foreign esters in essential oils
    2.8.7. Fatty oils and resinified essential oils in essential oils
    2.8.8. Odour and taste of essential oils
    2.8.9. Residue on evaporation of essential oils
    2.8.10. Solubility in alcohol of essential oils
    2.8.11. Assay of 1,8-cineole in essential oils
    2.8.12. Essential oils in herbal drugs
    2.8.13. Pesticide residues
    2.8.14. Tannins in herbal drugs
    2.8.15. Bitterness value
    2.8.16. Dry residue of extracts
    2.8.17. Loss on drying of extracts
    2.8.18. Determination of aflatoxin B1 in herbal drugs
    2.8.20. Herbal drugs sampling and sample preparation
    2.8.21. Test for aristolochic acids in herbal drugs
    2.8.22. Determination of ochratoxin A in herbal drugs
    2.8.23. Microscopic examination of herbal drugs
    2.8.24. Foam index
    2.8.25. High-performance thin-layer chromatography of herbal drugs and herbal drug preparations
    2.8.26. Contaminant pyrrolizidine alkaloids
    2.9.1. Disintegration of tablets and capsules
    2.9.2. Disintegration test for solid rectal and vaginal dosage forms
    2.9.3. Dissolution test for solid dosage forms
    2.9.4. Dissolution test for patches
    2.9.5. Uniformity of mass of single-dose preparations
    2.9.6. Uniformity of content of single-dose preparations
    2.9.7. Friability of uncoated tablets
    2.9.8. Resistance to crushing of tablets
    2.9.9. Measurement of consistency by penetrometry
    2.9.10. Ethanol content
    2.9.11. Test for methanol and 2-propanol
    2.9.12. Sieve test
    2.9.14. Specific surface area by air permeability
    2.9.16. Flowability
    2.9.17. Test for extractable volume of parenteral preparations
    2.9.18. Preparations for inhalation aerodynamic assessment of fine particles
    2.9.19. Particulate contamination sub-visible particles
    2.9.20. Particulate contamination visible particles
    2.9.22. Softening time determination of lipophilic suppositories
    2.9.23. Gas pycnometric density of solids
    2.9.25. Dissolution test for medicated chewing gums
    2.9.26. Specific surface area by gas adsorption
    2.9.27. Uniformity and accuracy of delivered doses from multidose containers
    2.9.29. Intrinsic dissolution
    2.9.31. Particle size analysis by laser light diffraction
    2.9.32. Porosity and pore-size distribution of solids by mercury porosimetry
    2.9.33. Characterisation of crystalline and partially crystalline solids by X-ray powder diffraction (XRPD)
    2.9.34. Bulk density and tapped density of powders
    2.9.35. Powder fineness
    2.9.36. Powder flow
    2.9.37. Optical microscopy
    2.9.38. Particle-size distribution estimation by analytical sieving
    2.9.39. Water-solid interactions determination of sorption-desorption isotherms and of water activity
    2.9.40. Uniformity of dosage units
    2.9.41. Friability of granules and spheroids
    2.9.42. Dissolution test for lipophilic solid dosage forms
    2.9.43. Apparent dissolution
    2.9.44. Preparations for nebulisation characterisation
    2.9.45. Wettability of porous solids including powders
    2.9.47. Demonstration of uniformity of dosage units using large sample sizes
    2.9.49. Powder flow properties by shear cell methods
    2.9.52. Scanning electron microscopy
    2.9.53. Particulate contamination sub-visible particles in non-injectable liquid preparations
    3.1. Materials used for the manufacture of containers
    3.1.3. Polyolefins
    3.1.4. Polyethylene without additives for containers for parenteral preparations and for ophthalmic preparations
    3.1.5. Polyethylene with additives for containers for parenteral preparations and for ophthalmic preparations
    3.1.6. Polypropylene for containers and closures for parenteral preparations and ophthalmic preparations
    3.1.7. Poly(ethylene - vinyl acetate) for containers and tubing for total parenteral nutrition preparations
    3.1.8. Silicone oil used as a lubricant
    3.1.9. Silicone elastomer for closures and tubing
    3.1.10. Materials based on non-plasticised poly(vinyl chloride) for containers for non-injectable, aqueous solutions
    3.1.11. Materials based on non-plasticised poly(vinyl chloride) for containers for solid dosage forms for oral administration
    3.1.13. Plastic additives
    3.1.14. Materials based on plasticised poly(vinyl chloride) for containers for aqueous solutions for intravenous infusion
    3.1.15. Polyethylene terephthalate for containers for preparations not for parenteral use
    3.2. Containers
    3.2.1. Glass containers for pharmaceutical use
    3.2.2. Plastic containers and closures for pharmaceutical use
    3.2.2.1. Plastic containers for aqueous solutions for infusion
    3.2.9. Rubber closures for containers for aqueous parenteral preparations, for powders and for freeze-dried powders
    3.3.1. Materials for containers for human blood and blood components
    3.3.2. Materials based on plasticised poly(vinyl chloride) for containers for human blood and blood components
    3.3.3. Materials based on plasticised poly(vinyl chloride) for tubing used in sets for the transfusion of blood and blood components
    3.3.4. Sterile plastic containers for human blood and blood components
    3.3.5. Empty sterile containers of plasticised poly(vinyl chloride) for human blood and blood components
    3.3.6. Sterile containers of plasticised poly(vinyl chloride) for human blood containing anticoagulant solution
    3.3.7. Sets for the transfusion of blood and blood components
    3.3.8. Sterile single-use plastic syringes
    3-O-Desacyl-4′-monophosphoryl lipid A
    4. Reagents
    4.1. Reagents, standard solutions, buffer solutions
    4.1.1. Reagents
    4-Aminobenzoic acid
    5.1.1. Methods of preparation of sterile products
    5.1.2. Biological indicators and related microbial preparations used in the manufacture of sterile products
    5.1.3. Efficacy of antimicrobial preservation
    5.1.4. Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use
    5.1.5. Application of the F concepts to heat sterilisation processes
    5.1.6. Alternative methods for control of microbiological quality
    5.1.7. Viral safety
    5.1.8. Microbiological quality of herbal medicinal products for oral use and extracts used in their preparation
    5.1.9. Guidelines for using the test for sterility
    5.1.10. Guidelines for using the test for bacterial endotoxins
    5.1.11. Determination of bactericidal, fungicidal or yeasticidal activity of antiseptic medicinal products
    5.1.12. Depyrogenation of items used in the production of parenteral preparations
    5.2.1. Terminology used in monographs on biological products
    5.2.2. Chicken flocks free from specified pathogens for the production and quality control of vaccines
    5.2.3. Cell substrates for the production of vaccines for human use
    5.2.4. Cell cultures for the production of vaccines for veterinary use
    5.2.5. Management of extraneous agents in immunological veterinary medicinal products
    5.2.6. Evaluation of safety of veterinary vaccines and immunosera
    5.2.7. Evaluation of efficacy of veterinary vaccines and immunosera
    5.2.8. Minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products
    5.2.9. Evaluation of safety of each batch of immunosera for veterinary use
    5.2.11. Carrier proteins for the production of conjugated polysaccharide vaccines for human use
    5.2.12. Raw materials of biological origin for the production of cell-based and gene therapy medicinal products
    5.2.13. Healthy chicken flocks for the production of inactivated vaccines for veterinary use
    5.2.14. Substitution of in vivo method(s) by in vitro method(s) for the quality control of vaccines
    5.3. Statistical analysis of results of biological assays and tests
    5.4. Residual solvents
    5.5. Alcoholimetric tables
    5.6. Assay of interferons
    5.7. Table of physical characteristics of radionuclides mentioned in the European Pharmacopoeia
    5.8. Pharmacopoeial harmonisation
    5.9. Polymorphism
    5.10. Control of impurities in substances for pharmaceutical use
    5.11. Characters section in monographs
    5.12. Reference standards
    5.14. Gene transfer medicinal products for human use
    5.15. Functionality-related characteristics of excipients
    5.16. Crystallinity
    5.17.1. Recommendations on dissolution testing
    5.17.2. Recommendations on testing of particulate contamination visible particles
    5.18. Methods of pretreatment for preparing traditional Chinese drugs general information
    5.19. Extemporaneous preparation of radiopharmaceuticals
    5.20. Elemental impurities
    5.21. Chemometric methods applied to analytical data
    5.22. Names of herbal drugs used in traditional Chinese medicine
    5.23. Monographs on herbal drug extracts (information chapter)
    5.24. Chemical imaging
    5.25. Process analytical technology
    5.26. Implementation of pharmacopoeial procedures
    5.28. Multivariate statistical process control
    5.30. Monographs on essential oils (information chapter)
    Abacavir sulfate
    Abelmoschi corolla
    Acacia
    Acacia, dried dispersion
    Acamprosate calcium
    Acanthopanax bark
    Acarbose
    Acebutolol hydrochloride
    Aceclofenac
    Acemetacin
    Acesulfame potassium
    Acetazolamide
    Acetic acid, glacial
    Acetone
    Acetylcholine chloride
    Acetylcysteine
    Acetylene intermix (1 per cent) in nitrogen
    Acetylsalicylic acid
    Achyranthes bidentata root
    Aciclovir
    Acidum picrinicum for homoeopathic preparations
    Acidum succinicum for homoeopathic preparations
    Acitretin
    Adapalene
    Adenine
    Adenosine
    Adipic acid
    Adonis vernalis for homoeopathic preparations
    Adrenaline
    Adrenaline tartrate
    Agar
    Agaricus phalloides for homoeopathic preparations
    Agnus castus fruit
    Agnus castus fruit dry extract
    Agrimony
    Air, medicinal
    Air, synthetic medicinal
    Akebia stem
    Alanine
    Albendazole
    Alchemilla
    Alcuronium chloride
    Alfacalcidol
    Alfadex
    Alfentanil hydrochloride hydrate
    Alfuzosin hydrochloride
    Alginic acid
    Alimemazine hemitartrate
    Allantoin
    Allergen products
    Allium sativum for homoeopathic preparations
    Allopurinol
    all-rac-Phytomenadione
    all-rac-α-Tocopherol
    all-rac-α-Tocopheryl acetate
    Almagate
    Almond oil, refined
    Almond oil, virgin
    Almotriptan malate
    Aloes dry extract, standardised
    Aloes, Barbados
    Aloes, Cape
    Alovudine (18F) injection
    Alprazolam
    Alprenolol hydrochloride
    Alprostadil
    Alteplase for injection
    Altizide
    Alum
    Aluminium chloride hexahydrate
    Aluminium hydroxide, hydrated, for adsorption
    Aluminium magnesium silicate
    Aluminium oxide, hydrated
    Aluminium phosphate gel
    Aluminium phosphate, hydrated
    Aluminium sodium silicate
    Aluminium stearate
    Aluminium sulfate
    Alverine citrate
    Amantadine hydrochloride
    Ambroxol hydrochloride
    Amfetamine sulfate
    Amidotrizoic acid dihydrate
    Amikacin
    Amikacin sulfate
    Amiloride hydrochloride dihydrate
    Aminocaproic acid
    Amiodarone hydrochloride
    Amisulpride
    Amitriptyline hydrochloride
    Amlodipine besilate
    Ammonia (13N) injection
    Ammonia solution, concentrated
    Ammonio methacrylate copolymer (type A)
    Ammonio methacrylate copolymer (type B)
    Ammonium bromide
    Ammonium carbonicum for homoeopathic preparations
    Ammonium chloride
    Ammonium glycyrrhizate
    Ammonium hydrogen carbonate
    Amomum fruit
    Amorolfine hydrochloride
    Amoxicillin sodium
    Amoxicillin trihydrate
    Amphotericin B
    Ampicillin
    Ampicillin sodium
    Ampicillin trihydrate
    Amprolium hydrochloride for veterinary use
    Amylmetacresol
    Anacardium for homoeopathic preparations
    Anastrozole
    Andrographis herb
    Anemarrhena asphodeloides rhizome
    Angelica archangelica root
    Angelica dahurica root
    Angelica pubescens root
    Angelica sinensis root
    Animal epithelia and outgrowths for allergen products
    Anise oil
    Aniseed
    Antazoline hydrochloride
    Anthrax spore vaccine (live) for veterinary use
    Anthrax vaccine for human use (adsorbed, prepared from culture filtrates)
    Anticoagulant and preservative solutions for human blood
    Anti-T lymphocyte immunoglobulin for human use, animal
    Apis for homoeopathic preparations
    Apomorphine hydrochloride hemihydrate
    Aprepitant
    Aprotinin
    Aprotinin concentrated solution
    Arachis oil, hydrogenated
    Arachis oil, refined
    Arginine
    Arginine aspartate
    Arginine hydrochloride
    Argon
    Aripiprazole
    Arnica flower
    Arnica tincture
    Arsenicum album for homoeopathic preparations
    Articaine hydrochloride
    Artichoke leaf
    Artichoke leaf dry extract
    Ascorbic acid
    Ascorbyl palmitate
    Ash leaf
    Asparagine monohydrate
    Aspartame
    Aspartic acid
    Astragalus mongholicus root
    Atazanavir sulfate
    Atenolol
    Atomoxetine hydrochloride
    Atorvastatin calcium
    Atovaquone
    Atractylodes lancea rhizome
    Atractylodes rhizome, largehead
    Atracurium besilate
    Atropine
    Atropine sulfate
    Aucklandia root
    Aujeszky’s disease vaccine (inactivated) for pigs
    Aujeszky’s disease vaccine (live) for pigs for parenteral administration
    Aurum chloratum natronatum for homoeopathic preparations
    Avian infectious bronchitis vaccine (inactivated)
    Avian infectious bronchitis vaccine (live)
    Avian infectious bursal disease vaccine (inactivated)
    Avian infectious bursal disease vaccine (live)
    Avian infectious encephalomyelitis vaccine (live)
    Avian infectious laryngotracheitis vaccine (live)
    Avian paramyxovirus 3 vaccine (inactivated) for turkeys
    Avian viral tenosynovitis vaccine (live)
    Azaperone for veterinary use
    Azathioprine
    Azelastine hydrochloride
    Azithromycin
    Bacampicillin hydrochloride
    Bacitracin
    Bacitracin zinc
    Baclofen
    Baical skullcap root
    Bambuterol hydrochloride
    Barbary wolfberry fruit
    Barium chloratum for homoeopathic preparations
    Barium sulfate
    Basic butylated methacrylate copolymer
    BCG for immunotherapy
    BCG vaccine, freeze-dried
    Bearberry leaf
    Beclometasone dipropionate
    Beclometasone dipropionate monohydrate
    Beeswax, white
    Beeswax, yellow
    Belamcanda chinensis rhizome
    Belladonna for homoeopathic preparations
    Belladonna leaf
    Belladonna leaf dry extract, standardised
    Belladonna leaf tincture, standardised
    Belladonna, prepared
    Benazepril hydrochloride
    Bendroflumethiazide
    Benperidol
    Benserazide hydrochloride
    Bentonite
    Benzalkonium chloride
    Benzalkonium chloride solution
    Benzbromarone
    Benzethonium chloride
    Benzocaine
    Benzoic acid
    Benzoin tincture, Siam
    Benzoin tincture, Sumatra
    Benzoin, Siam
    Benzoin, Sumatra
    Benzoyl peroxide, hydrous
    Benzydamine hydrochloride
    Benzyl alcohol
    Benzyl benzoate
    Benzylpenicillin (benzathine) tetrahydrate
    Benzylpenicillin (procaine) monohydrate
    Benzylpenicillin potassium
    Benzylpenicillin sodium
    Berberis aristata stem
    Betacarotene
    Betadex
    Betahistine dihydrochloride
    Betahistine mesilate
    Betamethasone
    Betamethasone acetate
    Betamethasone dipropionate
    Betamethasone sodium phosphate
    Betamethasone valerate
    Betaxolol hydrochloride
    Betiatide for radiopharmaceutical preparations
    Bezafibrate
    Bicalutamide
    Bifonazole
    Bilberry fruit, dried
    Bilberry fruit, fresh
    Biotin
    Biperiden hydrochloride
    Birch leaf
    Bisacodyl
    Bismuth subcarbonate
    Bismuth subgallate
    Bismuth subnitrate, heavy
    Bismuth subsalicylate
    Bisoprolol fumarate
    Bistort rhizome
    Bitter apricot seed
    Bitter-fennel fruit oil
    Bitter-fennel herb oil
    Bitter-orange epicarp and mesocarp
    Bitter-orange flower
    Bitter-orange-epicarp and mesocarp tincture
    Black cohosh
    Black horehound
    Blackcurrant leaf
    Bleomycin sulfate
    Bogbean leaf
    Boldine
    Boldo leaf
    Boldo leaf dry extract
    Borage (starflower) oil, refined
    Borax
    Bordetella bronchiseptica vaccine (live) for dogs
    Boric acid
    Botulinum antitoxin
    Botulinum toxin type A for injection
    Botulinum toxin type B for injection
    Bovine leptospirosis vaccine (inactivated)
    Bovine parainfluenza virus vaccine (live)
    Bovine respiratory syncytial virus vaccine (live)
    Bovine serum
    Bovine viral diarrhoea vaccine (inactivated)
    Brimonidine tartrate
    Bromazepam
    Bromhexine hydrochloride
    Bromocriptine mesilate
    Bromperidol
    Bromperidol decanoate
    Brompheniramine maleate
    Brotizolam
    Brucellosis vaccine (live) (Brucella melitensis Rev. 1 strain) for veterinary use
    Bryonia for homoeopathic preparations
    Buckwheat herb
    Budesonide
    Bufexamac
    Buflomedil hydrochloride
    Bumetanide
    Bupivacaine hydrochloride
    Bupleurum root
    Buprenorphine
    Buprenorphine hydrochloride
    Buserelin
    Buspirone hydrochloride
    Busulfan
    Butcher’s broom
    Butyl parahydroxybenzoate
    Butylhydroxyanisole
    Butylhydroxytoluene
    Cabergoline
    Cadmium sulfuricum for homoeopathic preparations
    Caffeine
    Caffeine monohydrate
    Calcifediol monohydrate
    Calcipotriol
    Calcipotriol monohydrate
    Calcitonin (salmon)
    Calcitriol
    Calcium acetate
    Calcium ascorbate dihydrate
    Calcium carbonate
    Calcium chloride dihydrate
    Calcium chloride hexahydrate
    Calcium dobesilate monohydrate
    Calcium fluoratum for homoeopathic preparations
    Calcium folinate hydrate
    Calcium glucoheptonate
    Calcium gluconate
    Calcium gluconate for injection
    Calcium gluconate, anhydrous
    Calcium glycerophosphate
    Calcium hydrogen phosphate
    Calcium hydrogen phosphate dihydrate
    Calcium hydroxide
    Calcium iodatum for homoeopathic preparations
    Calcium lactate
    Calcium lactate monohydrate
    Calcium lactate pentahydrate
    Calcium lactate trihydrate
    Calcium levofolinate hydrate
    Calcium levulinate dihydrate
    Calcium pantothenate
    Calcium phosphate
    Calcium stearate
    Calcium sulfate dihydrate
    Calendula flower
    Calf coronavirus diarrhoea vaccine (inactivated)
    Calf rotavirus diarrhoea vaccine (inactivated)
    Camphor, racemic
    Candesartan cilexetil
    Canine adenovirus vaccine (inactivated)
    Canine adenovirus vaccine (live)
    Canine distemper vaccine (live)
    Canine leptospirosis vaccine (inactivated)
    Canine parainfluenza virus vaccine (live)
    Canine parvovirosis vaccine (inactivated)
    Canine parvovirosis vaccine (live)
    Cape jasmine fruit
    Capecitabine
    Caprylic acid
    Caprylocaproyl macrogolglycerides
    Capsicum
    Capsicum oleoresin, refined and standardised
    Capsicum soft extract, standardised
    Capsicum tincture, standardised
    Capsules
    Captopril
    Caraway fruit
    Caraway oil
    Carbachol
    Carbamazepine
    Carbasalate calcium
    Carbidopa
    Carbimazole
    Carbocisteine
    Carbomers
    Carbon dioxide
    Carbon monoxide
    Carbon monoxide (15O)
    Carbon monoxide intermix (5 per cent) in nitrogen
    Carboplatin
    Carboprost trometamol
    Carmellose
    Carmellose calcium
    Carmellose sodium
    Carmellose sodium, low-substituted
    Carmustine
    Carnauba wax
    Carprofen for veterinary use
    Carrageenan
    Carteolol hydrochloride
    Carvedilol
    Cascara
    Cascara dry extract, standardised
    Cassia oil
    Castor oil, hydrogenated
    Castor oil, refined
    Castor oil, virgin
    Catgut, sterile
    Catgut, sterile, in distributor for veterinary use
    Cefaclor
    Cefadroxil monohydrate
    Cefalexin monohydrate
    Cefalotin sodium
    Cefamandole nafate
    Cefapirin sodium
    Cefatrizine propylene glycol
    Cefazolin sodium
    Cefepime dihydrochloride monohydrate
    Cefixime
    Cefoperazone sodium
    Cefotaxime sodium
    Cefoxitin sodium
    Cefpodoxime proxetil
    Cefprozil monohydrate
    Cefradine
    Ceftazidime pentahydrate
    Ceftazidime pentahydrate with sodium carbonate for injection
    Ceftriaxone sodium
    Cefuroxime axetil
    Cefuroxime sodium
    Celecoxib
    Celiprolol hydrochloride
    Cellulose acetate
    Cellulose acetate butyrate
    Cellulose acetate phthalate
    Cellulose, microcrystalline
    Cellulose, powdered
    Centaury
    Centella
    Cetirizine dihydrochloride
    Cetostearyl alcohol
    Cetostearyl alcohol (type A), emulsifying
    Cetostearyl alcohol (type B), emulsifying
    Cetostearyl isononanoate
    Cetrimide
    Cetyl alcohol
    Cetyl palmitate
    Cetylpyridinium chloride
    Chaenomeles fruit
    Chamomile flower, Roman
    Charcoal, activated
    Chemical precursors for radiopharmaceutical preparations
    Chenodeoxycholic acid
    Chewing gums, medicated
    Chinese goldthread rhizome
    Chinese motherwort
    Chitosan hydrochloride
    Chloral hydrate
    Chlorambucil
    Chloramphenicol
    Chloramphenicol palmitate
    Chloramphenicol sodium succinate
    Chlorcyclizine hydrochloride
    Chlordiazepoxide
    Chlordiazepoxide hydrochloride
    Chlorhexidine diacetate
    Chlorhexidine digluconate solution
    Chlorhexidine dihydrochloride
    Chlormadinone acetate
    Chlorobutanol
    Chlorobutanol hemihydrate
    Chlorocresol
    Chloroquine phosphate
    Chloroquine sulfate
    Chlorphenamine maleate
    Chlorpromazine hydrochloride
    Chlorprothixene hydrochloride
    Chlortalidone
    Chlortetracycline hydrochloride
    Cholecalciferol
    Cholecalciferol concentrate (oily form)
    Cholecalciferol concentrate (powder form)
    Cholera vaccine (inactivated, oral)
    Cholesterol
    Cholesterol for parenteral use
    Choline ([11C]methyl) injection
    Chondroitin sulfate sodium
    Chromium (51Cr) edetate injection
    Chymotrypsin
    Ciclesonide
    Ciclopirox
    Ciclopirox olamine
    Ciclosporin
    Cilastatin sodium
    Cilazapril
    Cimetidine
    Cimetidine hydrochloride
    Cinchocaine hydrochloride
    Cinchona bark
    Cinchona liquid extract, standardised
    Cineole
    Cinnamon
    Cinnamon bark oil, Ceylon
    Cinnamon leaf oil, Ceylon
    Cinnarizine
    Ciprofibrate
    Ciprofloxacin
    Ciprofloxacin hydrochloride
    Cisatracurium besilate
    Cisplatin
    Citalopram hydrobromide
    Citalopram hydrochloride
    Citric acid
    Citric acid monohydrate
    Citronella oil
    Cladribine
    Clarithromycin
    Clary sage oil
    Clazuril for veterinary use
    Clebopride malate
    Clemastine fumarate
    Clematis armandii stem
    Clenbuterol hydrochloride
    Clindamycin hydrochloride
    Clindamycin phosphate
    Clioquinol
    Clobazam
    Clobetasol propionate
    Clobetasone butyrate
    Clodronate disodium tetrahydrate
    Clofazimine
    Clofibrate
    Clomifene citrate
    Clomipramine hydrochloride
    Clonazepam
    Clonidine hydrochloride
    Clopamide
    Clopidogrel besilate
    Clopidogrel hydrochloride
    Clopidogrel hydrogen sulfate
    Closantel sodium dihydrate for veterinary use
    Clostridium botulinum vaccine for veterinary use
    Clostridium chauvoei vaccine for veterinary use
    Clostridium novyi (type B) vaccine for veterinary use
    Clostridium perfringens vaccine for veterinary use
    Clostridium septicum vaccine for veterinary use
    Clotrimazole
    Clove
    Clove oil
    Cloxacillin sodium
    Clozapine
    Cocaine hydrochloride
    Coccidiosis vaccine (live) for chickens
    Cocculus for homoeopathic preparations
    Cocoa butter
    Coconut oil, refined
    Cocoyl caprylocaprate
    Codeine hydrochloride dihydrate
    Codeine monohydrate
    Codeine phosphate hemihydrate
    Codeine phosphate sesquihydrate
    Codergocrine mesilate
    Cod-liver oil
    Cod-liver oil, farmed
    Codonopsis root
    Coix seed
    Cola
    Colchicine
    Colestyramine
    Colistimethate sodium
    Colistin sulfate
    Colophony
    Common selfheal fruit-spike
    Copovidone
    Copper sulfate
    Copper sulfate pentahydrate
    Copper tetramibi tetrafluoroborate for radiopharmaceutical preparations
    Coriander
    Coriander oil
    Cortisone acetate
    Corydalis rhizome
    Cotton, absorbent
    Cottonseed oil, hydrogenated
    Couch grass rhizome
    Cresol, crude
    Crocus for homoeopathic preparations
    Croscarmellose sodium
    Crospovidone
    Crotamiton
    Cuprum aceticum for homoeopathic preparations
    Cuprum metallicum for homoeopathic preparations
    Cyanocobalamin
    Cyanocobalamin (57Co) capsules
    Cyanocobalamin (57Co) solution
    Cyanocobalamin (58Co) capsules
    Cyanocobalamin (58Co) solution
    Cyathula root
    Cyclizine hydrochloride
    Cyclopentolate hydrochloride
    Cyclophosphamide monohydrate
    Cyproheptadine hydrochloride 1.5-hydrate
    Cyproterone acetate
    Cysteine hydrochloride monohydrate
    Cystine
    Cytarabine
    Dacarbazine
    Dalteparin sodium
    Danaparoid sodium
    Dandelion herb with root
    Dandelion root
    Dapsone
    Daunorubicin hydrochloride
    d-Camphor
    Decyl oleate
    Deferasirox
    Deferasirox dispersible tablets
    Deferiprone
    Deferiprone oral solution
    Deferiprone tablets
    Deferoxamine mesilate
    Dembrexine hydrochloride monohydrate for veterinary use
    Demeclocycline hydrochloride
    Deptropine citrate
    Dequalinium chloride
    Desflurane
    Desipramine hydrochloride
    Deslanoside
    Desloratadine
    Desmopressin
    Desogestrel
    Detomidine hydrochloride for veterinary use
    Devil’s claw dry extract
    Devil’s claw root
    Dexamethasone
    Dexamethasone acetate
    Dexamethasone isonicotinate
    Dexamethasone sodium phosphate
    Dexamfetamine sulfate
    Dexchlorpheniramine maleate
    Dexpanthenol
    Dextran 1 for injection
    Dextran 40 for injection
    Dextran 60 for injection
    Dextran 70 for injection
    Dextranomer
    Dextrin
    Dextromethorphan hydrobromide
    Dextromoramide tartrate
    Dextropropoxyphene hydrochloride
    Diacerein
    Diazepam
    Diazoxide
    Dibrompropamidine diisetionate
    Dibutyl phthalate
    Diclazuril for veterinary use
    Diclofenac potassium
    Diclofenac sodium
    Dicloxacillin sodium
    Dicycloverine hydrochloride
    Didanosine
    Dienogest
    Diethyl phthalate
    Diethylcarbamazine citrate
    Diethylene glycol monoethyl ether
    Diethylene glycol palmitostearate
    Difloxacin hydrochloride trihydrate for veterinary use
    Digitalis for homoeopathic preparations
    Digitalis leaf
    Digitoxin
    Digoxin
    Dihydralazine sulfate, hydrated
    Dihydrocodeine hydrogen tartrate
    Dihydroergocristine mesilate
    Dihydroergotamine mesilate
    Dihydrostreptomycin sulfate for veterinary use
    Dihydrotachysterol
    Diltiazem hydrochloride
    Dimenhydrinate
    Dimercaprol
    Dimethyl sulfoxide
    Dimethylacetamide
    Dimeticone
    Dimetindene maleate
    Dinoprost trometamol
    Dinoprostone
    Dioscorea nipponica rhizome
    Dioscorea oppositifolia rhizome
    Diosmin
    Diphenhydramine hydrochloride
    Diphenoxylate hydrochloride
    Diphtheria and tetanus vaccine (adsorbed)
    Diphtheria and tetanus vaccine (adsorbed, reduced antigen(s) content)
    Diphtheria antitoxin
    Diphtheria vaccine (adsorbed)
    Diphtheria vaccine (adsorbed, reduced antigen content)
    Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)
    Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content)
    Diphtheria, tetanus and pertussis (whole cell) vaccine (adsorbed)
    Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
    Diphtheria, tetanus, pertussis (acellular, component) and haemophilus type b conjugate vaccine (adsorbed)
    Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)
    Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
    Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)
    Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)
    Diphtheria, tetanus, pertussis (whole cell) and poliomyelitis (inactivated) vaccine (adsorbed)
    Dipivefrine hydrochloride
    Dipotassium clorazepate monohydrate
    Dipotassium phosphate
    Diprophylline
    Dipyridamole
    Dirithromycin
    Disodium edetate
    Disodium phosphate
    Disodium phosphate dihydrate
    Disodium phosphate dodecahydrate
    Disopyramide
    Disopyramide phosphate
    Distemper vaccine (live) for mustelids
    Disulfiram
    Dithranol
    dl-Lysine acetylsalicylate
    dl-Methionine
    Dl-α-Tocopheryl hydrogen succinate
    Dobutamine hydrochloride
    Docetaxel
    Docetaxel trihydrate
    Docusate sodium
    Dodecyl gallate
    Dog rose
    Domperidone
    Domperidone maleate
    Donepezil hydrochloride
    Donepezil hydrochloride monohydrate
    Dopamine hydrochloride
    Dopexamine dihydrochloride
    Dorzolamide hydrochloride
    Dosulepin hydrochloride
    Doxapram hydrochloride
    Doxazosin mesilate
    Doxepin hydrochloride
    Doxorubicin hydrochloride
    Doxycycline hyclate
    Doxycycline monohydrate
    Doxylamine hydrogen succinate
    Dronedarone hydrochloride
    Dronedarone tablets
    Droperidol
    Drospirenone
    Drynaria rhizome
    Duck plague vaccine (live)
    Duck viral hepatitis type I vaccine (live)
    Duloxetine hydrochloride
    Dutasteride
    Dwarf lilyturf tuber
    Dwarf pine oil
    Dydrogesterone
    Ear preparations
    Ebastine
    Eclipta herb
    Econazole
    Econazole nitrate
    Edetic acid
    Edrophonium chloride
    Egg drop syndrome ‘76 vaccine (inactivated)
    Egg phospholipids for injection
    Elder flower
    Eleutherococcus
    Emedastine difumarate
    Enalapril maleate
    Enalaprilat dihydrate
    Enilconazole for veterinary use
    Enoxaparin sodium
    Enoxolone
    Enrofloxacin for veterinary use
    Entacapone
    Entecavir monohydrate
    Enteric redmouth disease vaccine (inactivated) for rainbow trout
    Ephedra herb
    Ephedra vulgaris for homoeopathic preparations
    Ephedrine
    Ephedrine hemihydrate
    Ephedrine hydrochloride
    Ephedrine hydrochloride, racemic
    Epinastine hydrochloride
    Epirubicin hydrochloride
    Eplerenone
    Equine herpesvirus vaccine (inactivated)
    Equine influenza vaccine (inactivated)
    Equisetum stem
    Ergocalciferol
    Ergometrine maleate
    Ergotamine tartrate
    Erythritol
    Erythromycin
    Erythromycin estolate
    Erythromycin ethylsuccinate
    Erythromycin lactobionate
    Erythromycin stearate
    Erythropoietin concentrated solution
    Escitalopram
    Escitalopram oxalate
    Esketamine hydrochloride
    Esomeprazole magnesium dihydrate
    Esomeprazole magnesium trihydrate
    Esomeprazole sodium
    Essential oils
    Estradiol benzoate
    Estradiol hemihydrate
    Estradiol valerate
    Estriol
    Estrogens, conjugated
    Etacrynic acid
    Etamsylate
    Etanercept
    Ethacridine lactate monohydrate
    Ethambutol hydrochloride
    Ethanol (96 per cent)
    Ethanol, anhydrous
    Ethanolamine
    Ether
    Ethinylestradiol
    Ethionamide
    Ethosuximide
    Ethyl acetate
    Ethyl oleate
    Ethyl parahydroxybenzoate
    Ethylcellulose
    Ethylene glycol monopalmitostearate
    Ethylenediamine
    Ethylmorphine hydrochloride
    Etidronate disodium
    Etilefrine hydrochloride
    Etodolac
    Etofenamate
    Etomidate
    Etoposide
    Eucalyptus leaf
    Eucalyptus oil
    Eucommia bark
    Eugenol
    Evening primrose oil, refined
    Everolimus
    Evodia fruit
    Exemestane
    Eye preparations
    Famotidine
    Febantel for veterinary use
    Felbinac
    Feline calicivirosis vaccine (inactivated)
    Feline calicivirosis vaccine (live)
    Feline chlamydiosis vaccine (inactivated)
    Feline infectious enteritis (feline panleucopenia) vaccine (inactivated)
    Feline infectious enteritis (feline panleucopenia) vaccine (live)
    Feline leukaemia vaccine (inactivated)
    Feline viral rhinotracheitis vaccine (inactivated)
    Feline viral rhinotracheitis vaccine (live)
    Felodipine
    Felypressin
    Fenbendazole for veterinary use
    Fenbufen
    Fennel, bitter
    Fennel, sweet
    Fenofibrate
    Fenoterol hydrobromide
    Fentanyl
    Fentanyl citrate
    Fenticonazole nitrate
    Fenugreek
    Ferric chloride hexahydrate
    Ferrous fumarate
    Ferrous gluconate hydrate
    Ferrous sulfate heptahydrate
    Ferrous sulfate, dried
    Ferrum metallicum for homoeopathic preparations
    Feverfew
    Fexofenadine hydrochloride
    Fibrin sealant kit
    Filgrastim concentrated solution
    Filgrastim injection
    Finasteride
    Fingolimod hydrochloride
    Fipronil for veterinary use
    Fish oil, rich in omega-3 acids
    Flavoxate hydrochloride
    Flecainide acetate
    Fleeceflower root
    Flubendazole
    Flucloxacillin magnesium octahydrate
    Flucloxacillin sodium monohydrate
    Fluconazole
    Flucytosine
    Fludarabine phosphate
    Fludeoxyglucose (18F) injection
    Fludrocortisone acetate
    Flumazenil
    Flumazenil (N-[11C]methyl) injection
    Flumequine
    Flumetasone pivalate
    Flunarizine dihydrochloride
    Flunitrazepam
    Flunixin meglumine for veterinary use
    Fluocinolone acetonide
    Fluocortolone pivalate
    Fluorescein
    Fluorescein sodium
    Fluoride (18F) solution for radiolabelling
    Fluorocholine (18F) injection
    Fluorodopa (18F) (prepared by electrophilic substitution) injection
    Fluorodopa (18F) (prepared by nucleophilic substitution) injection
    Fluoroethyl-l-tyrosine (18F) injection
    Fluoromisonidazole (18F) injection
    Fluorouracil
    Fluoxetine hydrochloride
    Flupentixol dihydrochloride
    Fluphenazine decanoate
    Fluphenazine dihydrochloride
    Fluphenazine enantate
    Flurazepam monohydrochloride
    Flurbiprofen
    Fluspirilene
    Flutamide
    Fluticasone furoate
    Fluticasone propionate
    Flutrimazole
    Fluvastatin sodium
    Fluvoxamine maleate
    Foams, medicated
    Folic acid hydrate
    Follitropin
    Follitropin concentrated solution
    Foot-and-mouth disease (ruminants) vaccine (inactivated)
    Formaldehyde solution (35 per cent)
    Formic acid
    Formoterol fumarate dihydrate
    Forsythia fruit
    Foscarnet sodium hexahydrate
    Fosfomycin calcium
    Fosfomycin sodium
    Fosfomycin trometamol
    Fosinopril sodium
    Fourstamen stephania root
    Fowl cholera vaccine (inactivated)
    Fowl-pox vaccine (live)
    Framycetin sulfate
    Frangula bark
    Frangula bark dry extract, standardised
    Fraxinus chinensis bark
    Fresh bilberry fruit dry extract, refined and standardised
    Fructose
    Fulvestrant
    Fulvestrant injection
    Fumitory
    Furosemide
    Furunculosis vaccine (inactivated, oil-adjuvanted, injectable) for salmonids
    Fusidic acid
    Gabapentin
    Galantamine hydrobromide
    Gallium (67Ga) citrate injection
    Gallium (68Ga) chloride (accelerator-produced) solution for radiolabelling
    Gallium (68Ga) chloride solution for radiolabelling
    Gallium (68Ga) edotreotide injection
    Gallium (68Ga) PSMA-11 injection
    Gammadex
    Ganciclovir
    Ganoderma
    Garlic powder
    Gas-gangrene antitoxin (novyi)
    Gas-gangrene antitoxin (perfringens)
    Gas-gangrene antitoxin (septicum)
    Gas-gangrene antitoxin, mixed
    Gastrodia rhizome
    Gefitinib
    Gelatin
    Gemcitabine hydrochloride
    Gemfibrozil
    Gentamicin sulfate
    Gentian root
    Gentian tincture
    Gestodene
    Ginger
    Ginkgo dry extract, refined and quantified
    Ginkgo leaf
    Ginseng
    Ginseng dry extract
    Glibenclamide
    Gliclazide
    Glimepiride
    Glipizide
    Glossary
    Glucagon, human
    Glucosamine hydrochloride
    Glucosamine sulfate potassium chloride
    Glucosamine sulfate sodium chloride
    Glucose
    Glucose monohydrate
    Glucose, liquid
    Glucose, liquid, spray-dried
    Glutamic acid
    Glutathione
    Glycerol
    Glycerol (85 per cent)
    Glycerol dibehenate
    Glycerol distearate
    Glycerol formal
    Glycerol monocaprylate
    Glycerol monocaprylocaprate
    Glycerol monolinoleate
    Glycerol mono-oleate
    Glycerol monostearate 40-55
    Glyceryl trinitrate solution
    Glycine
    Glycopyrronium bromide
    Goldenrod
    Goldenrod, European
    Goldenseal rhizome
    Gonadorelin acetate
    Gonadotrophin, chorionic
    Goserelin
    Gramicidin
    Granisetron hydrochloride
    Granules
    Greater celandine
    Green tea
    Griseofulvin
    Guaiacol
    Guaifenesin
    Guanethidine monosulfate
    Guar
    Guar galactomannan
    Guarana
    Haemodialysis solutions, concentrated, water for diluting
    Haemodialysis, solutions for
    Haemofiltration and haemodiafiltration, concentrated solutions for
    Haemofiltration and haemodiafiltration, solutions for
    Haemophilus type b and meningococcal group C conjugate vaccine
    Haemophilus type b conjugate vaccine
    Halofantrine hydrochloride
    Haloperidol
    Haloperidol decanoate
    Halothane
    Hamamelis bark
    Hamamelis leaf
    Hard fat
    Hard fat with additives
    Hawthorn berries
    Hawthorn leaf and flower
    Hawthorn leaf and flower dry extract
    Hawthorn leaf and flower liquid extract
    Hedera helix for homoeopathic preparations
    Helium
    Heparin calcium
    Heparin sodium
    Heparins, low-molecular-mass
    Hepatitis A (inactivated) and hepatitis B (rDNA) vaccine (adsorbed)
    Hepatitis A (inactivated, adsorbed) and typhoid polysaccharide vaccine
    Hepatitis A vaccine (inactivated, adsorbed)
    Hepatitis A vaccine (inactivated, virosome)
    Hepatitis B vaccine (rDNA)
    Heptaminol hydrochloride
    Herbal drug extracts
    Herbal drug preparations
    Herbal drugs
    Herbal drugs for homoeopathic preparations
    Herbal drugs introduction
    Herbal teas
    Herbal teas, instant
    Hexamidine diisetionate
    Hexetidine
    Hexylresorcinol
    Histamine dihydrochloride
    Histaminum for homoeopathic preparations
    Histidine
    Histidine hydrochloride monohydrate
    Homatropine hydrobromide
    Homatropine methylbromide
    Homoeopathic pillules, coated
    Homoeopathic pillules, impregnated
    Homoeopathic preparations
    Homoeopathic preparations introduction
    Honey
    Hop strobile
    Horse-chestnut
    Horse-chestnut dry extract, standardised
    Houttuynia herb
    Human albumin injection, iodinated (125I)
    Human albumin solution
    Human anti-D immunoglobulin
    Human anti-D immunoglobulin for intravenous administration
    Human antithrombin III concentrate
    Human C1-esterase inhibitor
    Human coagulation factor IX
    Human coagulation factor IX (rDNA) concentrated solution
    Human coagulation factor IX (rDNA) powder for solution for injection
    Human coagulation factor VII
    Human coagulation factor VIIa (rDNA) concentrated solution
    Human coagulation factor VIII
    Human coagulation factor VIII (rDNA)
    Human coagulation factor XI
    Human fibrinogen
    Human haematopoietic stem cells
    Human hepatitis A immunoglobulin
    Human hepatitis B immunoglobulin
    Human hepatitis B immunoglobulin for intravenous administration
    Human measles immunoglobulin
    Human normal immunoglobulin for intramuscular administration
    Human normal immunoglobulin for intravenous administration
    Human normal immunoglobulin for subcutaneous administration
    Human papillomavirus vaccine (rDNA)
    Human plasma (pooled and treated for virus inactivation)
    Human plasma for fractionation
    Human prothrombin complex
    Human rabies immunoglobulin
    Human rubella immunoglobulin
    Human tetanus immunoglobulin
    Human varicella immunoglobulin
    Human varicella immunoglobulin for intravenous administration
    Human von Willebrand factor
    Human α-1-proteinase inhibitor
    Hyaluronidase
    Hydralazine hydrochloride
    Hydrastis canadensis for homoeopathic preparations
    Hydrochloric acid, concentrated
    Hydrochloric acid, dilute
    Hydrochlorothiazide
    Hydrocodone hydrogen tartrate 2.5-hydrate
    Hydrocortisone
    Hydrocortisone acetate
    Hydrocortisone hydrogen succinate
    Hydrogen peroxide solution (3 per cent)
    Hydrogen peroxide solution (30 per cent)
    Hydromorphone hydrochloride
    Hydroxocobalamin acetate
    Hydroxocobalamin chloride
    Hydroxocobalamin sulfate
    Hydroxycarbamide
    Hydroxychloroquine sulfate
    Hydroxyethyl salicylate
    Hydroxyethylcellulose
    Hydroxypropylbetadex
    Hydroxypropylcellulose
    Hydroxypropylcellulose, low-substituted
    Hydroxyzine hydrochloride
    Hymecromone
    Hymenoptera venoms for allergen products
    Hyoscine
    Hyoscine butylbromide
    Hyoscine hydrobromide
    Hyoscyamine sulfate
    Hyoscyamus for homoeopathic preparations
    Hypericum for homoeopathic preparations
    Hypromellose
    Hypromellose phthalate
    Ibandronate sodium monohydrate
    Ibuprofen
    Iceland moss
    Ichthammol
    Idoxuridine
    Ifosfamide
    Ignatia for homoeopathic preparations
    Imatinib mesilate
    Imidacloprid for veterinary use
    Imipenem monohydrate
    Imipramine hydrochloride
    Immunosera for human use, animal
    Immunosera for veterinary use
    Indapamide
    Indian frankincense
    Indigo plant leaf
    Indinavir sulfate
    Indium (111In) chloride solution
    Indium (111In) oxine solution
    Indium (111In) pentetate injection
    Indometacin
    Infectious bovine rhinotracheitis vaccine (inactivated)
    Infectious bovine rhinotracheitis vaccine (live)
    Infectious chicken anaemia vaccine (live)
    Infectious pancreatic necrosis vaccine (inactivated, oil-adjuvanted, injectable) for salmonids
    Infliximab concentrated solution
    Influenza vaccine (live, nasal)
    Influenza vaccine (split virion, inactivated)
    Influenza vaccine (surface antigen, inactivated)
    Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
    Influenza vaccine (surface antigen, inactivated, virosome)
    Influenza vaccine (whole virion, inactivated)
    Influenza vaccine (whole virion, inactivated, prepared in cell cultures)
    Insulin aspart
    Insulin glargine
    Insulin injection, biphasic isophane
    Insulin injection, isophane
    Insulin injection, soluble
    Insulin lispro
    Insulin preparations, injectable
    Insulin zinc injectable suspension
    Insulin zinc injectable suspension (amorphous)
    Insulin zinc injectable suspension (crystalline)
    Insulin, human
    Insulin, porcine
    Interferon alfa-2 concentrated solution
    Interferon beta-1a concentrated solution
    Interferon gamma-1b concentrated solution
    Intramammary preparations for veterinary use
    Intraruminal delivery systems
    Intrauterine preparations for veterinary use
    Intravesical preparations
    Iobenguane (123I) injection
    Iobenguane (131I) injection for diagnostic use
    Iobenguane (131I) injection for therapeutic use
    Iobenguane sulfate for radiopharmaceutical preparations
    Iodine
    Iodixanol
    Iodomethylnorcholesterol (131I) injection
    Iohexol
    Iopamidol
    Iopanoic acid
    Iopromide
    Iotrolan
    Ioxaglic acid
    Ipecacuanha liquid extract, standardised
    Ipecacuanha root
    Ipecacuanha tincture, standardised
    Ipecacuanha, prepared
    Ipratropium bromide
    Irbesartan
    Irinotecan hydrochloride trihydrate
    Isatis root
    Isoconazole
    Isoconazole nitrate
    Isoflurane
    Isoleucine
    Isomalt
    Isoniazid
    Isoprenaline hydrochloride
    Isoprenaline sulfate
    Isopropyl alcohol
    Isopropyl isostearate
    Isopropyl myristate
    Isopropyl palmitate
    Isosorbide dinitrate, diluted
    Isosorbide mononitrate, diluted
    Isotretinoin
    Isoxsuprine hydrochloride
    Ispaghula husk
    Ispaghula seed
    Isradipine
    Itraconazole
    Ivermectin
    Ivy leaf
    Java tea
    Josamycin
    Josamycin propionate
    Juniper
    Juniper oil
    Kalium bichromicum for homoeopathic preparations
    Kanamycin acid sulfate
    Kanamycin monosulfate
    Kaolin, heavy
    Kelp
    Ketamine hydrochloride
    Ketobemidone hydrochloride
    Ketoconazole
    Ketoprofen
    Ketorolac trometamol
    Ketotifen hydrogen fumarate
    Knotgrass
    Krypton (81mKr) inhalation gas
    Kudzuvine root
    Labetalol hydrochloride
    Lacosamide
    Lacosamide infusion
    Lacosamide oral solution
    Lacosamide tablets
    Lactic acid
    Lactitol monohydrate
    Lactobionic acid
    Lactose
    Lactose monohydrate
    Lactulose
    Lactulose, liquid
    Lamivudine
    Lamotrigine
    Lansoprazole
    Latanoprost
    Lauromacrogol 400
    Lauroyl macrogolglycerides
    Lavender flower
    Lavender oil
    Leflunomide
    Lemon oil
    Lemon verbena leaf
    Letrozole
    Leucine
    Leuprorelin
    Levamisole for veterinary use
    Levamisole hydrochloride
    Levetiracetam
    Levocabastine hydrochloride
    Levocarnitine
    Levodopa
    Levodropropizine
    Levofloxacin hemihydrate
    Levomenthol
    Levomepromazine hydrochloride
    Levomepromazine maleate
    Levomethadone hydrochloride
    Levonorgestrel
    Levothyroxine sodium
    Lidocaine
    Lidocaine hydrochloride monohydrate
    Lightyellow sophora root
    Ligusticum root and rhizome
    Lime flower
    Lincomycin hydrochloride
    Linen thread, sterile, in distributor for veterinary use
    Linoleoyl macrogolglycerides
    Linseed
    Linseed oil, virgin
    Liothyronine sodium
    Liquid preparations for cutaneous application
    Liquid preparations for oral use
    Liquorice dry extract for flavouring purposes
    Liquorice root
    Lisinopril dihydrate
    Lithium carbonate
    Lithium citrate
    Live biotherapeutic products for human use
    l-Methionine ([11C]methyl) injection
    Lobeline hydrochloride
    Lomustine
    Long pepper
    Loosestrife
    Loperamide hydrochloride
    Loperamide oxide monohydrate
    Lopinavir
    Loratadine
    Lorazepam
    Losartan potassium
    Lovage root
    Lovastatin
    Lufenuron for veterinary use
    Lutetium (177Lu) solution for radiolabelling
    Lycopus lucidus herb
    Lymecycline
    Lynestrenol
    Lysine acetate
    Lysine hydrochloride
    Macrogol 6 glycerol caprylocaprate
    Macrogol 15 hydroxystearate
    Macrogol 20 glycerol monostearate
    Macrogol 30 dipolyhydroxystearate
    Macrogol 40 sorbitol heptaoleate
    Macrogol cetostearyl ether
    Macrogol isotridecyl ether
    Macrogol lauryl ether
    Macrogol oleate
    Macrogol oleyl ether
    Macrogol poly(vinyl alcohol) grafted copolymer
    Macrogol stearate
    Macrogol stearyl ether
    Macrogolglycerol cocoates
    Macrogolglycerol hydroxystearate
    Macrogolglycerol ricinoleate
    Macrogols
    Macrogols, high-molecular-mass
    Magaldrate
    Magnesium acetate tetrahydrate
    Magnesium aluminometasilicate
    Magnesium aspartate dihydrate
    Magnesium carbonate, heavy
    Magnesium carbonate, light
    Magnesium chloride 4.5-hydrate
    Magnesium chloride hexahydrate
    Magnesium citrate
    Magnesium citrate dodecahydrate
    Magnesium citrate nonahydrate
    Magnesium fluoratum for homoeopathic preparations
    Magnesium gluconate
    Magnesium glycerophosphate
    Magnesium hydroxide
    Magnesium lactate dihydrate
    Magnesium oxide, heavy
    Magnesium oxide, light
    Magnesium peroxide
    Magnesium phosphoricum for homoeopathic preparations
    Magnesium pidolate
    Magnesium stearate
    Magnesium sulfate heptahydrate
    Magnesium trisilicate
    Magnolia biondii flower bud
    Magnolia officinalis bark
    Magnolia officinalis flower
    Maize oil, refined
    Maize starch
    Malathion
    Maleic acid
    Malic acid
    Mallow flower
    Mallow leaf
    Maltitol
    Maltitol, liquid
    Maltodextrin
    Mandarin epicarp and mesocarp
    Mandarin oil
    Mandragora for homoeopathic preparations
    Manganese gluconate
    Manganese glycerophosphate, hydrated
    Manganese sulfate monohydrate
    Mannheimia vaccine (inactivated) for cattle
    Mannheimia vaccine (inactivated) for sheep
    Mannitol
    Maprotiline hydrochloride
    Marbofloxacin for veterinary use
    Marek’s disease vaccine (live)
    Marshmallow leaf
    Marshmallow root
    Mastic
    Mate leaf
    Matricaria flower
    Matricaria liquid extract
    Matricaria oil
    Meadowsweet
    Measles vaccine (live)
    Measles, mumps and rubella vaccine (live)
    Measles, mumps, rubella and varicella vaccine (live)
    Mebendazole
    Mebeverine hydrochloride
    Meclozine dihydrochloride
    Medronic acid for radiopharmaceutical preparations
    Medroxyprogesterone acetate
    Mefenamic acid
    Mefloquine hydrochloride
    Megestrol acetate
    Meglumine
    Melatonin
    Meldonium dihydrate
    Melilot
    Melissa leaf
    Melissa leaf dry extract
    Meloxicam
    Melphalan
    Menadione
    Meningococcal group A, C, W135 and Y conjugate vaccine
    Meningococcal group C conjugate vaccine
    Meningococcal polysaccharide vaccine
    Menthol, racemic
    Mepivacaine hydrochloride
    Mepyramine maleate
    Mercaptopurine monohydrate
    Mercuric chloride
    Meropenem trihydrate
    Mesalazine
    Mesna
    Mesterolone
    Mestranol
    Metacresol
    Metamizole sodium monohydrate
    Metformin hydrochloride
    Methacrylic acid - ethyl acrylate copolymer (1 1)
    Methacrylic acid - ethyl acrylate copolymer (1 1) dispersion 30 per cent
    Methacrylic acid - methyl methacrylate copolymer (1 1)
    Methacrylic acid - methyl methacrylate copolymer (1 2)
    Methadone hydrochloride
    Methane
    Methane intermix (2 per cent) in nitrogen
    Methanol
    Methenamine
    Methionine
    Methods of preparation of homoeopathic stocks and potentisation
    Methotrexate
    Methyl nicotinate
    Methyl parahydroxybenzoate
    Methyl salicylate
    Methylaminolevulinate hydrochloride
    Methylcellulose
    Methyldopa
    Methylene chloride
    Methylergometrine maleate
    Methylhydroxyethylcellulose
    Methylphenidate hydrochloride
    Methylphenobarbital
    Methylprednisolone
    Methylprednisolone acetate
    Methylprednisolone hydrogen succinate
    Methylrosanilinium chloride
    Methyltestosterone
    Methylthioninium chloride hydrate
    Metixene hydrochloride
    Metoclopramide
    Metoclopramide hydrochloride monohydrate
    Metolazone
    Metoprolol succinate
    Metoprolol tartrate
    Metronidazole
    Metronidazole benzoate
    Mexiletine hydrochloride
    Mianserin hydrochloride
    Miconazole
    Miconazole nitrate
    Microcrystalline cellulose and carmellose sodium
    Midazolam
    Milbemycin oxime for veterinary use
    Milk thistle dry extract, refined and standardised
    Milk thistle fruit
    Minocycline hydrochloride dihydrate
    Minoxidil
    Mint oil, partly dementholised
    Mirabegron
    Mirtazapine
    Misoprostol
    Mites for allergen products
    Mitomycin
    Mitoxantrone hydrochloride
    Modafinil
    Molgramostim concentrated solution
    Molsidomine
    Mometasone furoate
    Mometasone furoate monohydrate
    Monoclonal antibodies for human use
    Montelukast sodium
    Morantel hydrogen tartrate for veterinary use
    Morinda root
    Morphine hydrochloride
    Morphine sulfate
    Mother tinctures for homoeopathic preparations
    Motherwort
    Moulds for allergen products
    Moutan bark
    Moxidectin for veterinary use
    Moxifloxacin hydrochloride
    Moxonidine
    Mullein flower
    Mumps vaccine (live)
    Mupirocin
    Mupirocin calcium
    Mycophenolate mofetil
    Mycophenolate sodium
    Mycoplasma gallisepticum vaccine (inactivated)
    myo-Inositol
    Myrrh
    Myrrh tincture
    Myxomatosis vaccine (live) for rabbits
    Nabumetone
    N-Acetyltryptophan
    N-Acetyltyrosine
    Nadolol
    Nadroparin calcium
    Naftidrofuryl hydrogen oxalate
    Naloxone hydrochloride dihydrate
    Naltrexone hydrochloride
    Nandrolone decanoate
    Naphazoline hydrochloride
    Naphazoline nitrate
    Naproxen
    Naproxen sodium
    Narrow-leaved coneflower root
    Nasal preparations
    Nateglinide
    Nebivolol hydrochloride
    Neohesperidin-dihydrochalcone
    Neomycin sulfate
    Neonatal piglet colibacillosis vaccine (inactivated)
    Neonatal ruminant colibacillosis vaccine (inactivated)
    Neostigmine bromide
    Neostigmine metilsulfate
    Neroli oil
    Netilmicin sulfate
    Nettle leaf
    Nettle root
    Nevirapine
    Nevirapine hemihydrate
    Newcastle disease vaccine (inactivated)
    Newcastle disease vaccine (live)
    Niaouli oil, cineole type
    Nicardipine hydrochloride
    Nicergoline
    Niclosamide
    Niclosamide monohydrate
    Nicorandil
    Nicotinamide
    Nicotine
    Nicotine ditartrate dihydrate
    Nicotine resinate
    Nicotinic acid
    Nifedipine
    Niflumic acid
    Nifuroxazide
    Nikethamide
    Nilotinib hydrochloride monohydrate
    Nilutamide
    Nimesulide
    Nimodipine
    Nitrazepam
    Nitrendipine
    Nitric acid
    Nitric oxide
    Nitrofural
    Nitrofurantoin
    Nitrogen
    Nitrogen, low-oxygen
    Nitrous oxide
    Nizatidine
    N-Methylpyrrolidone
    Nomegestrol acetate
    Nonoxinol 9
    Noradrenaline hydrochloride
    Noradrenaline tartrate
    Norethisterone
    Norethisterone acetate
    Norfloxacin
    Norflurane
    Norgestimate
    Norgestrel
    Nortriptyline hydrochloride
    Noscapine
    Noscapine hydrochloride hydrate
    Notoginseng root
    Notopterygium rhizome and root
    Nutmeg oil
    Nux-vomica for homoeopathic preparations
    Nystatin
    Oak bark
    Octoxinol 10
    Octreotide
    Octyl gallate
    Octyldodecanol
    Ofloxacin
    Olanzapine
    Olanzapine embonate monohydrate
    Oleic acid
    Oleoyl macrogolglycerides
    Oleyl alcohol
    Olive leaf
    Olive leaf dry extract
    Olive oil, refined
    Olive oil, virgin
    Olmesartan medoxomil
    Olsalazine sodium
    Omega-3-acid ethyl esters 60
    Omega-3-acid ethyl esters 90
    Omega-3-acid triglycerides
    Omeprazole
    Omeprazole magnesium
    Omeprazole sodium
    Ondansetron hydrochloride dihydrate
    Opium dry extract, standardised
    Opium tincture, standardised
    Opium, prepared
    Opium, raw
    Orbifloxacin for veterinary use
    Orciprenaline sulfate
    Oregano
    Orientvine stem
    Oromucosal preparations
    Orphenadrine citrate
    Orphenadrine hydrochloride
    Oseltamivir phosphate
    Ouabain
    Oxacillin sodium monohydrate
    Oxaliplatin
    Oxazepam
    Oxcarbazepine
    Oxeladin hydrogen citrate
    Oxfendazole for veterinary use
    Oxitropium bromide
    Oxolinic acid
    Oxybuprocaine hydrochloride
    Oxybutynin hydrochloride
    Oxycodone hydrochloride
    Oxygen
    Oxygen (15O)
    Oxygen (93 per cent)
    Oxymetazoline hydrochloride
    Oxytetracycline dihydrate
    Oxytetracycline hydrochloride
    Oxytocin
    Oxytocin concentrated solution
    Paclitaxel
    Pale coneflower root
    Palmitic acid
    Pamidronate disodium pentahydrate
    Pancreas powder
    Pancuronium bromide
    Pantoprazole sodium sesquihydrate
    Papaverine hydrochloride
    Paracetamol
    Paraffin, hard
    Paraffin, light liquid
    Paraffin, liquid
    Paraffin, white soft
    Paraffin, yellow soft
    Paraldehyde
    Parenteral preparations
    Parnaparin sodium
    Paroxetine hydrochloride
    Paroxetine hydrochloride hemihydrate
    Passionflower herb
    Passionflower herb dry extract
    Pasteurella vaccine (inactivated) for sheep
    Patches
    Pea starch
    Peach seed
    Pefloxacin mesilate dihydrate
    Pelargonium root
    Pemetrexed disodium 2.5-hydrate
    Pemetrexed disodium heptahydrate
    Penbutolol sulfate
    Penicillamine
    Pentaerythrityl tetranitrate, diluted
    Pentamidine diisetionate
    Pentazocine
    Pentazocine hydrochloride
    Pentazocine lactate
    Pentetate sodium calcium hydrate for radiopharmaceutical preparations
    Pentobarbital
    Pentobarbital sodium
    Pentoxifylline
    Pentoxyverine hydrogen citrate
    Peony root, red
    Peony root, white
    Pepper
    Peppermint leaf
    Peppermint leaf dry extract
    Peppermint oil
    Pepsin powder
    Pergolide mesilate
    Perindopril tert-butylamine
    Peritoneal dialysis, solutions for
    Permethrin (25 75)
    Perphenazine
    Pertussis vaccine (acellular, component, adsorbed)
    Pertussis vaccine (acellular, co-purified, adsorbed)
    Pertussis vaccine (whole cell, adsorbed)
    Peru balsam
    Pethidine hydrochloride
    Petroleum rectificatum for homoeopathic preparations
    Pharmaceutical preparations
    Phenazone
    Pheniramine maleate
    Phenobarbital
    Phenobarbital sodium
    Phenol
    Phenolphthalein
    Phenolsulfonphthalein
    Phenoxybenzamine hydrochloride
    Phenoxyethanol
    Phenoxymethylpenicillin
    Phenoxymethylpenicillin (benzathine) tetrahydrate
    Phenoxymethylpenicillin potassium
    Phentolamine mesilate
    Phenylalanine
    Phenylbutazone
    Phenylephrine
    Phenylephrine hydrochloride
    Phenylmercuric acetate
    Phenylmercuric borate
    Phenylmercuric nitrate
    Phenylpropanolamine hydrochloride
    Phenytoin
    Phenytoin sodium
    Phloroglucinol
    Phloroglucinol dihydrate
    Pholcodine monohydrate
    Phosphoric acid, concentrated
    Phosphoric acid, dilute
    Phthalylsulfathiazole
    Physostigmine salicylate
    Phytosterol
    Picotamide monohydrate
    Pillules for homoeopathic preparations
    Pilocarpine hydrochloride
    Pilocarpine nitrate
    Pimobendan for veterinary use
    Pimozide
    Pindolol
    Pine sylvestris oil
    Pioglitazone hydrochloride
    Pipemidic acid trihydrate
    Piperacillin monohydrate
    Piperacillin sodium
    Piperazine adipate
    Piperazine citrate
    Piperazine hydrate
    Piracetam
    Pirenzepine dihydrochloride monohydrate
    Piretanide
    Pirfenidone
    Piroxicam
    Pivampicillin
    Pivmecillinam hydrochloride
    Plasters, medicated
    Platycodon root
    Pneumococcal polysaccharide conjugate vaccine (adsorbed)
    Pneumococcal polysaccharide vaccine
    Podophyllotoxin
    Poliomyelitis vaccine (inactivated)
    Poliomyelitis vaccine (oral)
    Pollens for allergen products
    Poloxamers
    Poly(ethylene terephthalate) suture, sterile, in distributor for veterinary use
    Poly(vinyl acetate)
    Poly(vinyl acetate) dispersion 30 per cent
    Poly(vinyl alcohol)
    Polyacrylate dispersion 30 per cent
    Polyamide suture, sterile, in distributor for veterinary use
    Polygonum cuspidatum rhizome and root
    Polygonum orientale fruit
    Polymyxin B sulfate
    Polyoxypropylene stearyl ether
    Polysorbate 20
    Polysorbate 40
    Polysorbate 60
    Polysorbate 80
    Porcine actinobacillosis vaccine (inactivated)
    Porcine enzootic pneumonia vaccine (inactivated)
    Porcine influenza vaccine (inactivated)
    Porcine parvovirosis vaccine (inactivated)
    Porcine progressive atrophic rhinitis vaccine (inactivated)
    Poria
    Potassium acetate
    Potassium bromide
    Potassium carbonate
    Potassium chloride
    Potassium citrate
    Potassium clavulanate
    Potassium clavulanate, diluted
    Potassium dihydrogen phosphate
    Potassium hydrogen aspartate hemihydrate
    Potassium hydrogen carbonate
    Potassium hydrogen tartrate
    Potassium hydroxide
    Potassium iodide
    Potassium metabisulfite
    Potassium nitrate
    Potassium perchlorate
    Potassium permanganate
    Potassium sodium tartrate tetrahydrate
    Potassium sorbate
    Potassium sulfate
    Potato starch
    Povidone
    Povidone, iodinated
    Powders for cutaneous application
    Powders, oral
    Pramipexole dihydrochloride monohydrate
    Prasugrel hydrochloride
    Pravastatin sodium
    Prazepam
    Praziquantel
    Prazosin hydrochloride
    Prednicarbate
    Prednisolone
    Prednisolone acetate
    Prednisolone pivalate
    Prednisolone sodium phosphate
    Prednisone
    Pregabalin
    Premixes for medicated feeding stuffs for veterinary use
    Preparations for inhalation
    Preparations for irrigation
    Pressurised pharmaceutical preparations
    Prilocaine
    Prilocaine hydrochloride
    Primaquine diphosphate
    Primidone
    Primula root
    Probenecid
    Procainamide hydrochloride
    Procaine hydrochloride
    Prochlorperazine maleate
    Products of fermentation
    Products with risk of transmitting agents of animal spongiform encephalopathies
    Progesterone
    Proguanil hydrochloride
    Proline
    Promazine hydrochloride
    Promethazine hydrochloride
    Propacetamol hydrochloride
    Propafenone hydrochloride
    Propanol
    Propantheline bromide
    Propofol
    Propranolol hydrochloride
    Propyl gallate
    Propyl parahydroxybenzoate
    Propylene glycol
    Propylene glycol dicaprylocaprate
    Propylene glycol dilaurate
    Propylene glycol monocaprylate
    Propylene glycol monolaurate
    Propylene glycol monopalmitostearate
    Propylthiouracil
    Propyphenazone
    Protamine sulfate
    Protirelin
    Proxyphylline
    Pseudoephedrine hydrochloride
    PSMA-1007 (18F) injection
    Psyllium seed
    Pullulan
    Pulsatilla chinensis rhizome and root
    Pumpkin seed
    Purple coneflower herb
    Purple coneflower herb expressed juice, stabilised with ethanol
    Purple coneflower herb expressed juice, stabilised without ethanol
    Purple coneflower root
    Pygeum africanum bark
    Pyrantel embonate
    Pyrazinamide
    Pyridostigmine bromide
    Pyridoxine hydrochloride
    Pyrimethamine
    Pyrrolidone
    Quetiapine fumarate
    Quillaia bark
    Quinapril hydrochloride
    Quinidine sulfate
    Quinine hydrochloride dihydrate
    Quinine sulfate
    Rabbit haemorrhagic disease vaccine (inactivated)
    Rabeprazole sodium
    Rabeprazole sodium hydrate
    Rabies vaccine (inactivated) for veterinary use
    Rabies vaccine (live, oral) for foxes and raccoon dogs
    Rabies vaccine for human use prepared in cell cultures
    Racecadotril
    Raclopride ([11C]methoxy) injection
    Radiopharmaceutical preparations
    Raloxifene hydrochloride
    Raltegravir chewable tablets
    Raltegravir potassium
    Raltegravir tablets
    Ramipril
    Ranitidine hydrochloride
    Rapeseed oil, refined
    Raspberry leaf
    Recombinant DNA technology, products of
    Rectal preparations
    Red poppy petals
    Regorafenib monohydrate
    Regorafenib tablets
    Rehmannia root
    Remifentanil hydrochloride
    Repaglinide
    Reserpine
    Resorcinol
    Restharrow root
    Rhatany root
    Rhatany tincture
    Rhubarb
    Rhubarb dry extract, standardised
    Ribavirin
    Riboflavin
    Riboflavin sodium phosphate hydrate
    Ribwort plantain
    Rice starch
    Rifabutin
    Rifampicin
    Rifamycin sodium
    Rifaximin
    Rilmenidine dihydrogen phosphate
    Riociguat
    Riociguat tablets
    Risedronate sodium 2.5-hydrate
    Risperidone
    Ritonavir
    Rivaroxaban
    Rivaroxaban tablets
    Rivastigmine
    Rivastigmine hydrogen tartrate
    Rizatriptan benzoate
    Rocuronium bromide
    Ropinirole hydrochloride
    Ropivacaine hydrochloride monohydrate
    Roselle
    Rosemary leaf
    Rosemary oil
    Rosuvastatin calcium
    Rosuvastatin tablets
    Rotavirus vaccine (live, oral)
    Rotigotine
    Round amomum fruit
    Roxithromycin
    RRR-α-Tocopherol
    RRR-α-Tocopheryl acetate
    RRR-α-Tocopheryl hydrogen succinate
    Rubella vaccine (live)
    Rupatadine fumarate
    Rutoside trihydrate
    Saccharin
    Saccharin sodium
    Safflower flower
    Safflower oil, refined
    Sage leaf (Salvia officinalis)
    Sage leaf, three-lobed
    Sage tincture
    Salbutamol
    Salbutamol sulfate
    Salicylic acid
    Salmeterol xinafoate
    Salmon oil, farmed
    Salmonella Enteritidis vaccine (inactivated) for chickens
    Salmonella Enteritidis vaccine (live, oral) for chickens
    Salmonella Typhimurium vaccine (inactivated) for chickens
    Salmonella Typhimurium vaccine (live, oral) for chickens
    Salvia miltiorrhiza root and rhizome
    Sanguinaria for homoeopathic preparations
    Sanguisorba root
    Saposhnikovia root
    Saquinavir mesilate
    Saw palmetto extract
    Saw palmetto fruit
    Saxagliptin monohydrate
    Schisandra fruit
    Scrophularia root
    Selamectin for veterinary use
    Selegiline hydrochloride
    Selenium disulfide
    Selenium for homoeopathic preparations
    Semi-solid preparations for cutaneous application
    Senega root
    Senna fruit dry aqueous extract, standardised
    Senna fruit dry hydroalcoholic extract, standardised
    Senna leaflet
    Senna leaflet dry extract, standardised
    Senna pods
    Serine
    Serratula coronata herb
    Sertaconazole nitrate
    Sertraline hydrochloride
    Sesame oil, refined
    Sevoflurane
    Shellac
    Shepherd’s purse
    Shingles (herpes zoster) vaccine (live)
    Sildenafil citrate
    Silica, colloidal anhydrous
    Silica, colloidal hydrated
    Silica, dental type
    Silica, hydrophobic colloidal
    Silk suture, sterile, braided, in distributor for veterinary use
    Silver nitrate
    Silver, colloidal
    Simeticone
    Simvastatin
    Sitagliptin phosphate monohydrate
    Sitagliptin tablets
    Smallpox vaccine (live)
    Sodium (S)-lactate solution
    Sodium acetate ([1-11C]) injection
    Sodium acetate trihydrate
    Sodium alendronate trihydrate
    Sodium alginate
    Sodium amidotrizoate
    Sodium aminosalicylate dihydrate
    Sodium ascorbate
    Sodium aurothiomalate
    Sodium benzoate
    Sodium bromide
    Sodium calcium edetate
    Sodium caprylate
    Sodium carbonate
    Sodium carbonate decahydrate
    Sodium carbonate monohydrate
    Sodium cetostearyl sulfate
    Sodium chloride
    Sodium chromate (51Cr) sterile solution
    Sodium citrate
    Sodium cromoglicate
    Sodium cyclamate
    Sodium dihydrogen phosphate dihydrate
    Sodium ethyl parahydroxybenzoate
    Sodium fluoride
    Sodium fluoride (18F) injection
    Sodium fusidate
    Sodium glycerophosphate, hydrated
    Sodium hyaluronate
    Sodium hydrogen carbonate
    Sodium hydroxide
    Sodium iodide
    Sodium iodide (123I) injection
    Sodium iodide (123I) solution for radiolabelling
    Sodium iodide (131I) capsules for diagnostic use
    Sodium iodide (131I) capsules for therapeutic use
    Sodium iodide (131I) solution
    Sodium iodide (131I) solution for radiolabelling
    Sodium iodohippurate (123I) injection
    Sodium iodohippurate (131I) injection
    Sodium iodohippurate dihydrate for radiopharmaceutical preparations
    Sodium lactate solution
    Sodium laurilsulfate
    Sodium lauroylsarcosinate for external use
    Sodium metabisulfite
    Sodium methyl parahydroxybenzoate
    Sodium molybdate (99Mo) solution (fission)
    Sodium molybdate dihydrate
    Sodium nitrite
    Sodium nitroprusside
    Sodium perborate, hydrated
    Sodium pertechnetate (99mTc) injection (accelerator-produced)
    Sodium pertechnetate (99mTc) injection (fission)
    Sodium pertechnetate (99mTc) injection (non-fission)
    Sodium phenylbutyrate
    Sodium phosphate (32P) injection
    Sodium picosulfate
    Sodium polystyrene sulfonate
    Sodium propionate
    Sodium propyl parahydroxybenzoate
    Sodium pyrophosphate decahydrate for radiopharmaceutical preparations
    Sodium salicylate
    Sodium selenite
    Sodium selenite pentahydrate
    Sodium starch glycolate (type A)
    Sodium starch glycolate (type B)
    Sodium starch glycolate (type C)
    Sodium stearate
    Sodium stearyl fumarate
    Sodium sulfate decahydrate
    Sodium sulfate, anhydrous
    Sodium sulfite
    Sodium sulfite heptahydrate
    Sodium thiosulfate
    Sodium valproate
    Solifenacin succinate
    Solutions for organ preservation
    Somatostatin
    Somatropin
    Somatropin concentrated solution
    Somatropin injection
    Somatropin powder for injection
    Sophora flower
    Sophora flower-bud
    Sorafenib tablets
    Sorafenib tosilate
    Sorbic acid
    Sorbitan laurate
    Sorbitan oleate
    Sorbitan palmitate
    Sorbitan sesquioleate
    Sorbitan stearate
    Sorbitan trioleate
    Sorbitol
    Sorbitol, liquid (crystallising)
    Sorbitol, liquid (non-crystallising)
    Sorbitol, liquid, partially dehydrated
    Sotalol hydrochloride
    Soya phospholipids for injection
    Soya-bean oil, hydrogenated
    Soya-bean oil, refined
    Spanish sage oil
    Spectinomycin dihydrochloride pentahydrate
    Spectinomycin sulfate tetrahydrate for veterinary use
    Spike lavender oil
    Spiramycin
    Spirapril hydrochloride monohydrate
    Spironolactone
    Squalane
    Squalene
    St. John’s wort
    St. John’s wort dry extract, quantified
    Stannous chloride dihydrate
    Stanozolol
    Staphysagria for homoeopathic preparations
    Star anise
    Star anise oil
    Starch, hydroxypropyl
    Starch, hydroxypropyl, pregelatinised
    Starch, pregelatinised
    Starches, hydroxyethyl
    Stavudine
    Stearic acid
    Stearoyl macrogolglycerides
    Stearyl alcohol
    Sticks
    Stramonium for homoeopathic preparations
    Stramonium leaf
    Stramonium, prepared
    Strands, sterile non-absorbable, in distributor for veterinary use
    Streptokinase concentrated solution
    Streptomycin sulfate
    Strontium (89Sr) chloride injection
    Substances for pharmaceutical use
    Sucralfate
    Sucralose
    Sucrose
    Sucrose monopalmitate
    Sucrose stearate
    Sucrose, liquid
    Sufentanil
    Sufentanil citrate
    Sugar spheres
    Sulbactam sodium
    Sulfacetamide sodium
    Sulfadiazine
    Sulfadimethoxine
    Sulfadimethoxine sodium for veterinary use
    Sulfadimidine
    Sulfadoxine
    Sulfafurazole
    Sulfaguanidine
    Sulfamerazine
    Sulfamethizole
    Sulfamethoxazole
    Sulfamethoxypyridazine for veterinary use
    Sulfanilamide
    Sulfasalazine
    Sulfathiazole
    Sulfinpyrazone
    Sulfobutylbetadex sodium
    Sulfur
    Sulfur for homoeopathic preparations
    Sulfuric acid
    Sulindac
    Sulpiride
    Sultamicillin
    Sultamicillin tosilate dihydrate
    Sumatriptan succinate
    Sunflower oil, refined
    Sutures for human use introduction
    Sutures, sterile non-absorbable
    Sutures, sterile synthetic absorbable braided
    Sutures, sterile synthetic absorbable monofilament
    Suxamethonium chloride
    Suxibuzone
    Sweet orange oil
    Swine erysipelas vaccine (inactivated)
    Swine-fever vaccine (live, prepared in cell cultures), classical
    Szechwan lovage rhizome
    Tablets
    Tacalcitol monohydrate
    Tacrolimus monohydrate
    Tadalafil
    Talc
    Tamoxifen citrate
    Tampons, medicated
    Tamsulosin hydrochloride
    Tannic acid
    Tapentadol hydrochloride
    Tartaric acid
    Tea tree oil
    Technetium (99mTc) bicisate injection
    Technetium (99mTc) colloidal rhenium sulfide injection
    Technetium (99mTc) colloidal tin injection
    Technetium (99mTc) etifenin injection
    Technetium (99mTc) exametazime injection
    Technetium (99mTc) gluconate injection
    Technetium (99mTc) human albumin injection
    Technetium (99mTc) macrosalb injection
    Technetium (99mTc) mebrofenin injection
    Technetium (99mTc) medronate injection
    Technetium (99mTc) mertiatide injection
    Technetium (99mTc) microspheres injection
    Technetium (99mTc) oxidronate injection
    Technetium (99mTc) pentetate injection
    Technetium (99mTc) sestamibi injection
    Technetium (99mTc) succimer injection
    Technetium (99mTc) tin pyrophosphate injection
    Teicoplanin
    Telmisartan
    Temazepam
    Temozolomide
    Tenoxicam
    Terazosin hydrochloride dihydrate
    Terbinafine hydrochloride
    Terbutaline sulfate
    Terconazole
    Terfenadine
    Teriflunomide
    Teriflunomide tablets
    Teriparatide
    Terlipressin
    Terpin monohydrate
    Testosterone
    Testosterone decanoate
    Testosterone enantate
    Testosterone isocaproate
    Testosterone propionate
    Tetanus antitoxin for human use
    Tetanus antitoxin for veterinary use
    Tetanus vaccine (adsorbed)
    Tetanus vaccine for veterinary use
    Tetracaine
    Tetracaine hydrochloride
    Tetracosactide
    Tetracycline
    Tetracycline hydrochloride
    Tetra-O-acetyl-mannose triflate for radiopharmaceutical preparations
    Tetrazepam
    Tetryzoline hydrochloride
    Thallous (201Tl) chloride injection
    Theophylline
    Theophylline monohydrate
    Theophylline-ethylenediamine
    Theophylline-ethylenediamine hydrate
    Thiamazole
    Thiamine hydrochloride
    Thiamine nitrate
    Thiamphenicol
    Thiocolchicoside crystallised from ethanol
    Thiocolchicoside hydrate
    Thioctic acid
    Thiomersal
    Thiopental sodium and sodium carbonate
    Thioridazine
    Thioridazine hydrochloride
    Thomson kudzuvine root
    Threonine
    Thunberg fritillary bulb
    Thyme
    Thyme oil, thymol type
    Thymol
    Tiabendazole
    Tiamulin for veterinary use
    Tiamulin hydrogen fumarate for veterinary use
    Tianeptine sodium
    Tiapride hydrochloride
    Tiaprofenic acid
    Tibolone
    Ticagrelor
    Ticagrelor tablets
    Ticarcillin sodium
    Tick-borne encephalitis vaccine (inactivated)
    Ticlopidine hydrochloride
    Tigecycline
    Tilidine hydrochloride hemihydrate
    Timolol maleate
    Tinidazole
    Tinzaparin sodium
    Tioconazole
    Tiotropium bromide monohydrate
    Titanium dioxide
    Tizanidine hydrochloride
    Toadflax herb
    Tobramycin
    Tolbutamide
    Tolfenamic acid
    Tolnaftate
    Tolterodine tartrate
    Tolu balsam
    Topiramate
    Torasemide
    Tormentil
    Tormentil tincture
    Tosylchloramide sodium
    Toxicodendron quercifolium for homoeopathic preparations
    Tragacanth
    Tramadol hydrochloride
    Tramazoline hydrochloride monohydrate
    Trandolapril
    Tranexamic acid
    Trapidil
    Trazodone hydrochloride
    Trehalose dihydrate
    Tretinoin
    Triacetin
    Triamcinolone
    Triamcinolone acetonide
    Triamcinolone hexacetonide
    Triamterene
    Tribenoside
    Tributyl acetylcitrate
    Trichloroacetic acid
    Triclabendazole for veterinary use
    Triethyl citrate
    Trifluoperazine hydrochloride
    Trifluridine
    Triflusal
    Triglycerides, medium-chain
    Triglycerol diisostearate
    Trihexyphenidyl hydrochloride
    Trimebutine maleate
    Trimetazidine dihydrochloride
    Trimethadione
    Trimethoprim
    Trimipramine maleate
    Tri-n-butyl phosphate
    Tritiated (3H) water injection
    Trolamine
    Trometamol
    Tropicamide
    Tropisetron hydrochloride
    Trospium chloride
    Troxerutin
    Trypsin
    Tryptophan
    Tuberculin for human use, old
    Tuberculin purified protein derivative for human use
    Tuberculin purified protein derivative, avian
    Tuberculin purified protein derivative, bovine
    Turkey infectious rhinotracheitis vaccine (live)
    Turmeric rhizome
    Turmeric, Javanese
    Turpentine oil
    Tylosin for veterinary use
    Tylosin phosphate bulk solution for veterinary use
    Tylosin phosphate for veterinary use
    Tylosin tartrate for veterinary use
    Typhae pollen
    Typhoid polysaccharide vaccine
    Typhoid vaccine
    Typhoid vaccine (live, oral, strain Ty 21a)
    Tyrosine
    Tyrothricin
    Ubidecarenone
    Uncaria stem with hooks
    Undecylenic acid
    Urea
    Urofollitropin
    Urokinase
    Ursodeoxycholic acid
    Urtica dioica for homoeopathic preparations
    Vaccines for human use
    Vaccines for veterinary use
    Vaginal preparations
    Valaciclovir hydrochloride
    Valaciclovir hydrochloride hydrate
    Valerian dry aqueous extract
    Valerian dry hydroalcoholic extract
    Valerian root
    Valerian root, cut
    Valerian tincture
    Valganciclovir hydrochloride
    Valine
    Valnemulin hydrochloride for veterinary use
    Valproic acid
    Valsartan
    Vancomycin hydrochloride
    Vanillin
    Vardenafil hydrochloride trihydrate
    Varicella vaccine (live)
    Vecuronium bromide
    Vedaprofen for veterinary use
    Vegetable fatty oils
    Venlafaxine hydrochloride
    Verapamil hydrochloride
    Verbena herb
    Veterinary liquid preparations for cutaneous application
    Veterinary semi-solid preparations for oral use
    Vibriosis (cold-water) vaccine (inactivated) for salmonids
    Vibriosis vaccine (inactivated) for salmonids
    Vibriosis vaccine (inactivated) for sea bass
    Vigabatrin
    Vinblastine sulfate
    Vincamine
    Vincristine sulfate
    Vindesine sulfate
    Vinorelbine tartrate
    Vinpocetine
    Viper venom antiserum, European
    Viscose wadding, absorbent
    Vitamin A
    Vitamin A concentrate (oily form), synthetic
    Vitamin A concentrate (powder form), synthetic
    Vitamin A concentrate (solubilisate emulsion), synthetic
    Voriconazole
    Warfarin sodium
    Warfarin sodium clathrate
    Water (15O) injection
    Water for injections
    Water for preparation of extracts
    Water, purified
    Wheat starch
    Wheat-germ oil, refined
    Wheat-germ oil, virgin
    White horehound
    Wild pansy (flowering aerial parts)
    Wild thyme
    Willow bark
    Willow bark dry extract
    Wool alcohols
    Wool fat
    Wool fat, hydrogenated
    Wool fat, hydrous
    Wormwood
    Xanthan gum
    Xenon (133Xe) injection
    Xylazine hydrochloride for veterinary use
    Xylitol
    Xylometazoline hydrochloride
    Xylose
    Yarrow
    Yellow fever vaccine (live)
    Yohimbine hydrochloride
    Yttrium (90Y) chloride solution for radiolabelling
    Zanamivir hydrate
    Zanthoxylum bungeanum pericarp
    Zidovudine
    Zinc acetate dihydrate
    Zinc acexamate
    Zinc chloride
    Zinc gluconate
    Zinc oxide
    Zinc stearate
    Zinc sulfate heptahydrate
    Zinc sulfate hexahydrate
    Zinc sulfate monohydrate
    Zinc undecylenate
    Ziprasidone hydrochloride monohydrate
    Ziprasidone mesilate trihydrate
    Zoledronic acid monohydrate
    Zolmitriptan
    Zolpidem tartrate
    Zopiclone
    Zuclopenthixol decanoate
    α-Tocopheryl acetate concentrate (powder form)
    β-Acetyldigoxin
                    

    برچسب ها :

    دارونامه گياهي , دارونامه گياهي اروپا, دانلود فارماکوپه اروپا, دانلود مونوگراف , فارماکوپه اروپا, فارماکوپه انگليس , فارماکوپه اروپا, فارماکوپه اروپا 2023 , متن کامل کتاب فارماکوپه اروپا , مونوگراف , مونوگراف گياهان دارويي

    European Pharmacopoeia , European Pharmacopoeia medicinal plants , دارونامه اروپا, دارونامه گیاهی اروپا, دانلود دارونامه اروپا, دانلود رایگان فارماکوپه گیاهی اروپا, دانلود فارماکوپه , دانلود فارماکوپه اروپا, دانلود فارماکوپه گیاهی , فارماکوپه اروپا, فارماکوپه اروپا, متن کامل کتاب فارماکوپه اروپا

  • دانلود کتاب Highway Capacity Manual 7th Edition

    دانلود کتاب Highway Capacity Manual 7th Edition

    خرید ایبوک Highway Capacity Manual: A Guide for Multimodal Mobility Analysis

    برای دانلود کتاب Highway Capacity Manual: A Guide for Multimodal Mobility Analysis و دانلود کتاب راهنمای ظرفیت بزرگراه: راهنمای تحلیل تحرک چندوجهی بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود استاندارد ایمیل می شود.استاندارد در فرمت PDF اسکن شده و به زبان انگلیسی ارسال می شود.نسخه الکترونیکی استاندارد قابلیت کپی برداری copy و Paste دارد.

    در صورتی که نیاز به پی دی اف هر استانداردی از AISC دارید، کافیست مشخصات استاندارد American Institute of steel construction درخواستی را برای گیگاپیپر ارسال کنید. کلیه شماره استانداردهاي سازه هاي فولادي آمريکا موجود است.

    خرید ایبوک Highway Capacity Manual

    Highway Capacity Manual 7th Edition A Guide for Multimodal Mobility Analysis (2022)

    Publication Info

    1286 pages |  8.5 x 11 | 

    ISBNs: 

    • Paperback:  978-0-309-08766-7
    • Ebook:  978-0-309-27562-0

    DOI: https://doi.org/10.17226/26432

    https://nap.nationalacademies.org/catalog/26432/highway-capacity-manual-7th-edition-a-guide-for-multimodal-mobility

    دانلود استاندارد Highway Capacity Manual 7th Edition

    Transportation engineers have used editions of the Highway Capacity Manual (HCM) in their analyses for decades. The HCM is the fundamental reference for concepts, performance measures, and analysis techniques for evaluating the multimodal operation of streets, highways, freeways, and off-street paths. This 3-volume 7th Edition contains new information, including new planning-level methods for connected and automated vehicles; a completely revised procedure for analyzing two-lane highways; a new procedure for evaluating systems of freeways and arterials with queue spillback; and updated methodologies for pedestrian operations at uncontrolled and signalized crossings.

    دانلود کتاب راهنمای ظرفیت بزرگراه: راهنمای تحلیل تحرک چندوجهی

    مهندسان حمل و نقل دهه‌هاست که از نسخه‌های مختلف راهنمای ظرفیت بزرگراه (HCM) در تحلیل‌های خود استفاده می‌کنند. HCM مرجع اساسی برای مفاهیم، ​​معیارهای عملکرد و تکنیک‌های تحلیل برای ارزیابی عملکرد چندوجهی خیابان‌ها، بزرگراه‌ها، آزادراه‌ها و مسیرهای خارج از خیابان است. این ویرایش هفتم سه جلدی شامل اطلاعات جدیدی از جمله روش‌های جدید در سطح برنامه‌ریزی برای وسایل نقلیه متصل و خودکار؛ یک رویه کاملاً اصلاح‌شده برای تحلیل بزرگراه‌های دو بانده؛ یک رویه جدید برای ارزیابی سیستم‌های آزادراه‌ها و شریانی‌ها با قابلیت بازگشت صف؛ و روش‌های به‌روز شده برای عملیات عابران پیاده در گذرگاه‌های کنترل‌نشده و چراغ‌دار است.

  • دانلود کتاب The Handbook of International Crisis and Risk Communication Research, 2nd Edition

    دانلود کتاب The Handbook of International Crisis and Risk Communication Research, 2nd Edition

    خرید ایبوک The Handbook of International Crisis and Risk Communication Research

    برای دانلود ایبوک The Handbook of International Crisis and Risk Communication Research (Handbooks in Communication and Media) و خرید کتاب کتاب راهنمای تحقیقات ارتباطات بین المللی بحران بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود کتاب ایمیل می شود.این ایبوک در فرمت PDF اورجینال به همراه Epub و به زبان انگلیسی ارسال می شود.نسخه الکترونیکی کتاب قابلیت کپی برداری copy و Paste دارد.

    در صورتی که نیاز به پی دی اف هر کتابی از انتشارات وایلی دارید با گیگاپیپر مکاتبه کنید.

    خرید کتاب The Handbook of International Crisis and Risk Communication Research

    The Handbook of International Crisis and Risk Communication Research, 2nd Edition

    Andreas Schwarz (Editor), Matthew W. Seeger (Editor), Sora Kim (Editor)

    ISBN: 978-1-394-18083-7 April 2025 720 pages

    Publisher ‏ : ‎ Wiley; 2nd edition (April 22, 2025)

    Language ‏ : ‎ English

    Hardcover ‏ : ‎ 720 pages

    ISBN-10 ‏ : ‎ 1394180802 – eText ISBN:9781394180837

    ISBN-13 ‏ : ‎ 978-1394180806

    Send email to download :ایمیل گیگاپیپر دانلود کتاب مقاله پایان نامه

    Price : 25$

    https://www.wiley.com/en-us/The+Handbook+of+International+Crisis+and+Risk+Communication+Research%2C+2nd+Edition-p-9781394180837
    
    https://www.vitalsource.com/en-au/products/the-handbook-of-international-crisis-and-risk-andreas-schwarz-v9781394180837?srsltid=AfmBOoo2dHUszA0FrGSpLnfIxqN_EDzEwZPzYTNhIe3yBD6AJ0vOrALC
    https://www.amazon.com/Handbook-International-Communication-Research-Handbooks/dp/1394180802

    دانلود رایگان کتاب The Handbook of International Crisis and Risk Communication Research 2nd Edition

    The Handbook of International Crisis and Risk Communication Research
    English | 2025 | ISBN: 1394180802 | 688 Pages | PDF , EPUB (True) | 12 MB

    Now in its second edition, The Handbook of International Crisis and Risk Communication Research offers a timely and comprehensive exploration of the methods, challenges, and innovations in managing present-day global crises and risks. Bringing together expert insights from across the fields of communication, public relations, and social sciences, this interdisciplinary volume examines crisis and risk communication through an international lens. Each chapter presents unique cultural, theoretical, and methodological perspectives for managing risk, mitigating crises, and fostering resilience.

    Amid growing transnational issues such as public health emergencies, climate-induced disasters, and political upheavals, the Handbook emphasizes the role of communication in crisis awareness, recovery, and renewal. Contributions by leading scholars and practitioners investigate vital issues such as the impact of misinformation, digital technologies, and media dynamics in shaping public perception and policy response. This revised and expanded edition also reflects recent global threats, including climate change, the COVID-19 pandemic, the war in Ukraine, and other cross-border crises.

    Equipping readers with the knowledge and frameworks necessary to navigate an increasingly complex and interconnected world, The Handbook of International Crisis and Risk Communication Research is perfect for advanced graduate courses and PhD programs in crisis and risk communication, as well as crisis managers, public relations consultants, communication officers, and scholars in risk management and communication.

    دانلود کتابچه راهنمای تحقیقات ارتباطات بحران و ریسک بین‌المللی 2025

    اکنون در ویرایش دوم خود، «راهنمای تحقیقات ارتباطات بحران و ریسک بین‌المللی» کاوشی به‌موقع و جامع در روش‌ها، چالش‌ها و نوآوری‌ها در مدیریت بحران‌ها و ریسک‌های جهانی امروزی ارائه می‌دهد. این کتاب میان‌رشته‌ای با گردآوری بینش‌های متخصصان از حوزه‌های مختلف ارتباطات، روابط عمومی و علوم اجتماعی، ارتباطات بحران و ریسک را از دریچه‌ای بین‌المللی بررسی می‌کند. هر فصل، دیدگاه‌های فرهنگی، نظری و روش‌شناختی منحصر به فردی را برای مدیریت ریسک، کاهش بحران‌ها و تقویت تاب‌آوری ارائه می‌دهد.

    در بحبوحه مسائل رو به رشد فراملی مانند فوریت‌های بهداشت عمومی، بلایای ناشی از آب و هوا و تحولات سیاسی، این کتاب بر نقش ارتباطات در آگاهی‌بخشی، بهبود و نوسازی بحران تأکید می‌کند. مشارکت‌های محققان و متخصصان برجسته، مسائل حیاتی مانند تأثیر اطلاعات نادرست، فناوری‌های دیجیتال و پویایی رسانه‌ها را در شکل‌دهی به ادراک عمومی و واکنش به سیاست‌ها بررسی می‌کند. این نسخه اصلاح‌شده و گسترش‌یافته همچنین تهدیدات جهانی اخیر، از جمله تغییرات اقلیمی، همه‌گیری کووید-۱۹، جنگ در اوکراین و سایر بحران‌های فرامرزی را منعکس می‌کند.

    «کتابچه راهنمای تحقیقات ارتباطات بحران و ریسک بین‌المللی» با تجهیز خوانندگان به دانش و چارچوب‌های لازم برای پیمایش در جهانی که به طور فزاینده‌ای پیچیده و به هم پیوسته است، برای دوره‌های تحصیلات تکمیلی پیشرفته و برنامه‌های دکترا در ارتباطات بحران و ریسک، و همچنین مدیران بحران، مشاوران روابط عمومی، مسئولان ارتباطات و محققان در مدیریت ریسک و ارتباطات، ایده‌آل است.

    فهرست مطالب The Handbook of International Crisis and Risk Communication Research

    1. Cover
    2. Table of Contents
    3. Series Page
    4. Title Page
    5. Copyright Page
    6. List of Contributors
    7. Preface and Acknowledgments
    8. Part I: History, Status Quo, and Trends in Global Crisis and Risk Communication Research
    9. 1 Global Threats and the Significance of International Risk and Crisis Communication Research: Advancing Integration, Diversity, and Complexity
    10. The State of International Crisis and Risk Communication Research
    11. Goals and Structure of the Handbook
    12. References
    13. Author’s Bio
    14. 2 History of Crisis and Risk Communication
    15. Introduction
    16. Crisis Communication
    17. Multidisciplinary Approaches
    18. Risk Communication
    19. Theoretical and Interdisciplinary Perspectives
    20. The Relationship Between Crisis and Risk Communication
    21. Future Developments
    22. Conclusion
    23. References
    24. Author’s Bio
    25. 3 Beyond Borders and Bridging Worlds
    26. Why Culture Matters in Risk and Crisis Communication?
    27. Cultural Investigation Matrix in International Crisis and Risk Communication
    28. The Status of Research on Culture in Crisis and Risk Communication
    29. Theoretical and Methodological Framework of Culture Research in Risk and Crisis Communication
    30. Challenges and Future Directions in Cultural Investigations
    31. References
    32. Author’s Bio
    33. Part II: Strategic and Institutional Communicators in International Crises and Risks
    34. 4 Military, Government, and Media Management in Wartime
    35. Introduction
    36. Military Media Management
    37. Government–Media Relationships in Wartime – Theoretical Models
    38. Digitization and Emerging Voices in War Communication
    39. Conclusion and Implications for Communicator Research
    40. References
    41. Author Bio
    42. 5 Crisis Communication in the Context of Terrorism
    43. Multi‐Actor Response Network
    44. The Process Approach, from Preparedness to Recovery
    45. Concluding Remarks
    46. Acknowledgments
    47. References
    48. Author’s Bio
    49. 6 Paradigms of Risk and Crisis Communication and the Threat of Misinformation and Disinformation
    50. Risk Communication Paradigms
    51. Crisis Communication Paradigms
    52. Misinformation and Disinformation in the Social Construction of Risk and Crisis Communication
    53. Conclusion
    54. References
    55. Author’s Bio
    56. 7 Strategic Communication in Global Health Crises
    57. Mitigating Cross‐Border Health Crises Requires Effective Communication
    58. The “Fragmented Array” of Health Crisis Response
    59. Strategic Government Communications in Times of Multiple Health Crises
    60. Risk Cultures and Political Systems Shape How Health Crises are Communicated
    61. Cross‐Sector Collaboration, Policy‐Science Relationships, and Recipient‐Centeredness
    62. References
    63. Author’s Bio
    64. 8 International Organizational Crisis Communication
    65. Introduction
    66. International Organizational Crisis Communication
    67. Simple Rules: An Approach to Engaging Dynamic and Complex Contexts
    68. Simple Rules for Managing the Complexity of International Crisis Communication
    69. Simple Communication Rules Organizations Should Follow During a Crisis
    70. Simple Communication Rules Organizations Should Not Follow During a Crisis
    71. Conclusion
    72. References
    73. Authors’ Bio
    74. 9 Political Crises
    75. Three Subfields of Crisis Management
    76. Political Arenas – Stakeholders, Interest Groups, and Voters
    77. Four Research Traditions of Political Crisis and Crisis Communication
    78. Conclusions
    79. References
    80. Author’s Bio
    81. Part III: The Role of Legacy Media and Social Media in International Crises and Risks
    82. 10 War Reporting in an Evolving Media Landscape
    83. Introduction
    84. Re‐Imagining War Journalism: War, Crisis, and Mediatization
    85. Layers of Influence: Factors Affecting War Reporting as a Practice
    86. “Othering” and War‐Mongering: State of the Art and Issues in Media Coverage
    87. Paradigm‐Shifters: War Reporting and New Technologies
    88. Conclusion
    89. References
    90. Author’s Bio
    91. 11 Terrorism, Lone Wolf Shootings, School Shootings, and the Role of (Social) Media
    92. Introduction
    93. Terrorism and School Shootings as Crisis and Risk
    94. Media as Part of the Perpetrators’ Strategies
    95. The Role of Social Media
    96. Contagious and Incentivizing Effects on Would‐be Mass Killers
    97. Guidelines and Censorship – Yes or No?
    98. Conclusion and Outlook
    99. References
    100. Author’s Bio
    101. 12 Environmental Risk Communication
    102. Environmental Risk Communication
    103. ERC’s Evolution
    104. Additional ERC Frameworks
    105. Three Major ERC Challenges
    106. Conclusion
    107. References
    108. Author’s Bio
    109. 13 Missed Risk and Crisis Communication Opportunities During the COVID‐19 Pandemic
    110. Missed Opportunity: Follow Crisis and Emergency Risk Communication Principles
    111. Missed Opportunity: Include Communication Experts at the Decision‐making Table
    112. Missed Opportunity: Faster Recognition of and Response to the Power of Misinformation
    113. Missed Opportunity: Audience‐specific Messaging
    114. Lessons Learned about Applying Risk and Crisis Communication Best Practices
    115. Future Research
    116. Conclusion
    117. References
    118. Author’s Bios
    119. 14 The Role of Legacy Media and Social Media in International Organizational Risk and Crisis Communication
    120. Introduction
    121. The Role of Legacy Media in Organizational Risk and Crisis Communication
    122. The Role of Social Media in Shaping Organizational Risk and Crisis Communication
    123. Future Research and Conclusion
    124. References
    125. Author’s Bio
    126. 15 Political Crisis Communication and the Rhetorical Arena
    127. Introduction
    128. Defining Political Crisis and Political Crisis Communication
    129. The Rhetorical Arena
    130. The Challenges of Crisis Communication
    131. The Successes of Crisis Communication
    132. The Images and Narratives of Crisis Communication
    133. Crisis Communication on Instagram
    134. Crisis Communication on Twitter/X
    135. Conclusion
    136. References
    137. Author’s Bio
    138. Part IV: The Role of Audiences, Citizens, and Victims in International Crises and Risks
    139. 16 War, Media, and Public Opinion
    140. Introduction
    141. Casualties and Public Opinion
    142. Mueller’s Hypothesis – Log of Cumulative Casualties
    143. National, Local, and Marginal Casualties
    144. Media, Casualties, and Public Opinion
    145. Social Media, Disinformation, and Public Support for War
    146. The Ukraine War: A Case Study
    147. Conclusion
    148. References
    149. Author Bio
    150. 17 Communicating Terrorism
    151. Introduction
    152. What is Terrorism?
    153. The History of Terrorism
    154. Communicating Terrorism
    155. The Symbolism of Terror
    156. How do Audiences Make Sense of Terror?
    157. Conclusion
    158. References
    159. Author Bio
    160. 18 Reoccurring Challenges and Emerging Threats
    161. Introduction
    162. Information Seeking
    163. Secondary Audience Reactions
    164. Addressing Variability in Psychological Responses
    165. Migration
    166. Knowledge Gaps
    167. Specific Channels
    168. Measurement and Research in Disasters and Pandemics
    169. Conclusion
    170. References
    171. Author’s Bio
    172. 19 The Role of Audiences, Citizens, and Victims in International Crises
    173. Major Audiences
    174. Coping with Uncertainty During a Public Health Crisis
    175. Media and (Digital) Health Literacy
    176. Risk Perception and the Impact of Media Use
    177. Infodemics and Their Consequences
    178. Areas of Future Research
    179. References
    180. Author’s Bio
    181. 20 Domestic and International Audiences of Organizational Risk and Crisis Communication
    182. The Importance of Responsibility
    183. Attributing and Accepting Responsibility Around the Globe
    184. Covariation
    185. Making Room for Emotions
    186. The Importance of Sending the Right Message, the Right Way
    187. Risk Communication
    188. Conclusion
    189. References
    190. Author’s Bio
    191. 21 Reputational Crisis in Politics
    192. Character and Reputation
    193. The Habitus of Political Reputation Management
    194. Challenges to Political Reputation
    195. Audience‐Centric Responses to Reputational Crisis
    196. Conclusions
    197. References
    198. Author Bio
    199. Part V: The State of Crisis and Risk Communication Research Around the Globe
    200. Crisis and Risk Communication Research in Africa
    201. 22 Crisis Communication in East Africa
    202. Introduction
    203. The Context of Risk and Crisis Communication Research in East Africa
    204. The State of Research in Risk and Crisis Communication in East Africa
    205. Risk Communication in Three East African Countries: The Case of COVID‐19
    206. References
    207. Author’s Bio
    208. 23 The Role of Customary Crisis Communication Mechanisms in Ethiopia
    209. Introduction
    210. Brief Overview of Crisis Communication Literature in Ethiopia
    211. Overview of Crisis Communication Literature on COVID‐19 and 737 MAX Crisis
    212. Traditional/Customary Crisis Communication Mechanisms in Natural and Man‐Made Crisis Situations
    213. Ethiopia and Traditional Crisis Communication Practices
    214. The Culture of Communicating Crisis and Customary Methods
    215. Current State of Customary Crisis Management Mechanisms
    216. Conclusion
    217. References
    218. Authors’ Bio
    219. 24 Culture, Ethnicity, and Religion
    220. Introduction
    221. Nigeria: Country Profile
    222. The Context of Crisis Communication Research in Nigeria
    223. Culture and Crisis Communication in Nigeria
    224. COVID‐19: Success Factors
    225. Case Study 2: The 2022 Catastrophic Flooding
    226. Conclusion
    227. References
    228. Authors’ Bio
    229. Crisis and Risk Communication Research in Asia
    230. 25 Crisis Communication Research in South Korea
    231. Introduction
    232. State of Research in Risk and Crisis Communication in South Korea
    233. Institutional Perspectives
    234. Media Perspectives
    235. Public Perspectives
    236. Conclusion and Areas of Future Research
    237. References
    238. Author’s Bio
    239. 26 Risk and Crisis Communication Research in Singapore
    240. Introduction
    241. References
    242. 26.A Appendix
    243. Author’s Bio
    244. 27 Risk and Crisis Communication Research in China
    245. Introduction
    246. The Status of Risk and Crisis Communication in China
    247. Risk and Crisis Communication in China: Key Findings
    248. Case Study: 2022 MU5735 Airplane Crash
    249. Conclusion
    250. References
    251. Authors’ Bio
    252. 28 Risk and Crisis Communication Research in India
    253. Introduction
    254. Definition of Risk and Crisis Communication in the Indian Context
    255. Risk and Disaster Communication in India
    256. The Media/Journalism Perspective
    257. Audience Perspective
    258. Analysis of COVID‐19 Crisis Communication by the Government of India
    259. Concluding Thoughts
    260. References
    261. Author’s Bio
    262. 29 Risk Communication Research and Practice in Japan
    263. The Context of Risk and Crisis Communication in Japan
    264. The State of Research in Risk and Crisis Communication
    265. Practical Cases of Risk Communication
    266. Concluding Remarks
    267. References
    268. Author Bio
    269. Crisis and Risk Communication Research in the Middle East
    270. 30 Crisis and Risk Communication Research in Israel
    271. Introduction
    272. Research Output
    273. Findings
    274. Discussion
    275. Conclusion
    276. References
    277. Author’s Bio
    278. 31 Risk and Crisis Communication Research
    279. Introduction
    280. The Context of Risk and Crisis Communication Research in the GCC Countries
    281. The State of Research in Risk and Crisis Communication in the GCC Countries
    282. Handling of Crises: PR Consultants (Foreign vs. Local)
    283. Crisis and Risk Management Research
    284. Conclusion and Areas of Future Research
    285. References
    286. Author Bio
    287. Crisis and Risk Communication Research in Europe
    288. 32 Crisis and Risk Communication Research in Germany
    289. The Context of Crisis Communication Research in Germany
    290. Crises and the Emergence of Risk and Crisis Communication Research in Germany
    291. The State of German Risk and Crisis Communication Research
    292. Conclusion and Outlook
    293. References
    294. Author’s Bio
    295. 33 Risk and Crisis Communication Research in the Nordic Countries
    296. Introduction
    297. New Crisis Landscape and Interrelatedness Between Crisis Management Subfields
    298. The Context of Crisis Communication Research in the Nordic Countries
    299. Risk and Crisis Communication Research in Sweden
    300. Risk and Crisis Communication Research in Denmark
    301. Risk and Crisis Communication Research in Norway
    302. Risk and Crisis Communication Research in Finland
    303. Risk and Crisis Communication Research in Iceland
    304. References
    305. Author’s Bio
    306. 34 Revisiting the Challenges of Crisis Management and Crisis Communication Research in Russia1
    307. Introduction
    308. Perceptions and Responses to Risks and Crises
    309. Crisis Management Actors: State Versus the Rest
    310. The Role of the Media as a Crisis Actor
    311. Audience Perceptions of Risks and Safety
    312. Future Research and Conclusions
    313. References
    314. Author’s Bio
    315. 35 Risk and Crisis Communication Research in Romania
    316. Societal Context of Risk and Crisis Communication in Romania
    317. Academic Context of Risk and Crisis Communication in Romania
    318. Perspectives of Risk and Crisis Communication Research in Romania
    319. Academic Programs
    320. Research and Academic Publications
    321. Development of the Communication and Public Relations Industry
    322. National Framework and Regulations for Academic Programs
    323. Conclusion
    324. References
    325. Author’s Bio
    326. 36 Crisis and Risk Communication Research in Eastern Europe
    327. Main Regional Trends in Crisis and Risk Communication
    328. Context of Crisis Communication Studies
    329. Ukraine and the Baltic Countries
    330. Ukraine
    331. Baltic Countries
    332. The V4‐Cluster: Czech Republic, Hungary, Poland, and Slovakia
    333. Media Perspective
    334. Institutional Perspective
    335. Audience Perspective
    336. Crisis Communication Theory and Discourse in the V4 Countries
    337. Trends and Issues in Crisis Communication Research in the Region
    338. References
    339. Authors’ Bio
    340. Crisis and Risk Communication Research in the Americas
    341. 37 Risk and Crisis Communication Research in North America
    342. Risk Communication
    343. Crisis Communication
    344. Stage Models and Best Practices
    345. Conclusion
    346. References
    347. Author Bio
    348. 38 Risk and Crisis Communication in Latin America
    349. The Context of Risk and Crisis Communication in Latin America
    350. Methodology
    351. Results
    352. Institutional Perspective of Risk and Crisis Communication Research in Latin America
    353. Media Perspective of Risk and Crisis Communication Research in Latin America
    354. Audience Perspective of Risk and Crisis Communication Research in Latin America
    355. Case Study: Risk and Crisis Communication During the COVID‐19 Pandemic in Latin America and Colombia
    356. Conclusion
    357. References
    358. Author’s Bio
    359. 39 Risk and Crisis Communication Research in Brazil
    360. The State of Risk and Crisis Communication Research in Brazil
    361. Risk and Crisis Communication in Brazil – Relevant cases from the past 10 years
    362. Leadership Insensitivity During the COVID‐19 Pandemic and the Impact on People
    363. The Water Crisis in São Paulo
    364. Failure to Learn: The Case of Vale and the Collapse of Two Mining Dams
    365. Conclusion
    366. References
    367. Authors’ Bio
    368. 40 Crisis, Risk, and Media Cases in Argentina
    369. Introduction
    370. Before 2001: Corporate Crisis
    371. Since 2001: Media Cases
    372. During the Pandemic: Managing Risk
    373. Conclusion
    374. References
    375. Author Bio
    376. Crisis and Risk Communication Research in Australia and Oceania
    377. 41 Risk and Crisis Communication in Australia and New Zealand
    378. Introduction
    379. Context
    380. Organization‐Specific Crises and Risks
    381. Public Crises and Risks
    382. Future Research and Conclusions
    383. References
    384. Author’s Bio
    385. Part VI: Emerging Topics, Challenges, Theory, and Methods
    386. Conceptual and Theoretical Developments and Challenges in Crisis and Risk Communication
    387. 42 International Crises as Wicked Problems and Mega‐crises: Opportunities for Building Crisis Communication Theory on an International Level
    388. Introduction
    389. The Increasing Complexity of Crises and Crisis Communication
    390. Wicked Problems
    391. Mega‐Crisis
    392. Frequency and Form of Recent International Risk and Crisis Communication Research
    393. International Research on Disasters
    394. International Research on Digital Crisis Communication
    395. International Research on Pandemics
    396. International Research on “Other” Topics
    397. Conclusions and Implications
    398. References
    399. Authors’ Bio
    400. 43 Instructional Communication Theories, Models, and Constructs in Risk/Mega‐Risk and Crisis/Mega‐Crisis
    401. Driving Forces for Theory Expansion
    402. Instructional Communication
    403. Theoretical Tenets and Constructs of Instructional Communication
    404. IDEA Model
    405. Conclusion
    406. References
    407. Author Bio
    408. 44 Risk‐based Approaches to Crisis Management and Communication
    409. Introduction
    410. Definitions: Crisis and Risk
    411. Why does Risk Science Matter?
    412. A Survivor’s Guide for Crisis Management and Communication
    413. Conclusion
    414. References
    415. Author Bio
    416. Methodological Developments and Challenges in Crisis and Risk Communication Research
    417. 45 Aligning the Field: Embracing the Interdisciplinary, Conceptually Divergent, and Methodological Diverse Reality of Good Research in Risk and Crisis Communication
    418. Two Paths Diverging in the Woods: Risk and Crisis Communication Epistemology
    419. PR Epistemology in Risk and Crisis Communication
    420. Organizational Communication Epistemology in Risk and Crisis Communication
    421. Methodological and Disciplinary Diversity in Risk and Crisis Communication Research
    422. Methodological Diversity in Risk and Crisis Communication Research
    423. Disciplinary Diversity in Risk and Crisis Communication Research
    424. Current Needs for Improving Research Design in Risk and Crisis Communication
    425. Supporting Diverse Voices in Risk and Crisis Communication Research
    426. Aligning Theory and Research Design
    427. References
    428. Author Bio
    429. 46 Opportunities and Pitfalls of Computational Communication Science for International Risk and Crisis Communication Research
    430. Definition of Terms and Scope
    431. The Present: Primary Issues, Topics, and Areas of Work
    432. CCS in Crisis Communication Research
    433. The Future: Opportunities, Challenges, Pitfalls
    434. Conclusion
    435. References
    436. Author Bio
    437. 47 Methodological Challenges of International Crisis Communication Research1
    438. Introduction
    439. Basic Research Concerns: Culture, Nations, Analytic Frameworks, and Focus
    440. Key Challenges for International Crisis Communication Researchers
    441. Evaluative Criteria for International Research
    442. Summary
    443. Conclusion
    444. References
    445. Author Bio
    446. Technologies and Practices in International Crisis and Risk Communication
    447. 48 Technologies in Crisis Communication: Tools, Systems, and Infrastructures
    448. Scope
    449. Technology as Tool, System, and Infrastructure
    450. Research on Technologies in Crisis Communication
    451. Future Research Directions
    452. Conclusion
    453. References
    454. Author Bio
    455. 49 Preparing for International and Cross‐Cultural Crises: The Challenges of Research in Action, Competing Voices, Inclusivity, and the Interplay of Responsibility in Global Organizations
    456. Foundations and Functions of International Response to Cross‐Border Crises
    457. Foundations: Legal Framework for International Health Emergency Response
    458. Functions: WHO Doctrine for International Risk and Crisis Communication
    459. Challenges in International Risk and Crisis Communication
    460. Coordinating Research and Emergency Response Practice
    461. Inclusivity
    462. Competing Voices
    463. Interplay of Responsibilities
    464. Conclusions
    465. References
    466. Author’s Bio
    467. Summing Up & Looking Ahead: The Future of International Risk & Crisis Communication Research
    468. 50 The Expanding and Dynamic Field of Crisis and Emergency Risk Communication: Summary, Implications, and Outlook
    469. Introduction
    470. An Expanding, International Field, Driven by Events (Part I)
    471. The Emergence of more, and more Diverse Organizational and Institutional Actors (Part II)
    472. The Rise of Mis/Disinformation, the Impact of AI, and the Lack of Global South Perspectives: The Role of News Media and Social Media in Global Risk and Crisis Communication (Part III)
    473. The Interconnectedness of Audiences, Citizens, and Victims in Crisis Dynamics (Part IV)
    474. Risk and Crisis Communication Research in Different World Regions: Global Threats, Local Challenges, and Emerging Global South Perspectives (Part V)
    475. Summary
    476. Conclusions
    477. References
    478. Author’s Bio
    479. Index
    480. End User License Agreement
  • دانلود استاندارد AAMI ST91 خرید Flexible and semi-rigid endoscope processing in health care facilities

    دانلود استاندارد AAMI ST91 خرید Flexible and semi-rigid endoscope processing in health care facilities

    خرید استاندارد AAMI ST91:2021

    برای دانلود استاندارد AAMI ST91 و خرید استاندارد Flexible and semi-rigid endoscope processing in health care facilities بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود استاندارد ایمیل می شود.استاندارد در فرمت PDF و به زبان انگلیسی و مربوط به سال 2021 ارسال می شود.نسخه الکترونیکی استاندارد قابلیت کپی برداری copy و Paste دارد.

    در صورتی که نیاز به پی دی اف هر استانداردی از AAMI دارید، کافیست مشخصات استاندارد Association for the Advancement of Medical Instrumentation درخواستی را برای گیگاپیپر ارسال کنید. کلیه شماره انجمن پيشبرد ابزار دقيق پزشکي موجود است.

    خرید استاندارد AAMI ST 91

    استاندارد AAMI استاندارد های AAMI پکیج کامل استاندارد AAMI  ، مجموعه کامل استاندارد AAMI ، خرید استاندارد AAMI خرید پکیج استاندارد انجمن تجهیزات پیشرفته پزشکی دانلود استاندارد دانلود استاندارد AAMI دانلود استاندارد AAMI 2019 دانلود رایگان استاندارد AAMI  فروش استاندارد AAMI

    AAMI ST91:2021

    Flexible and semi-rigid endoscope processing in health care facilities

    standard by Association for the Advancement of Medical Instrumentation , 12/21/2021

    https://store.accuristech.com/standards/aami-st91-2021?product_id=2248551

    دانلود استاندارد AAMI ST-91

    Provides guidelines for point of use treatment, transporting, leak testing (where indicated), cleaning, packaging (where indicated), high-level disinfecting and/or sterilizing, storage, and quality control procedures of flexible gastrointestinal (GI) endoscopes, flexible bronchoscopes, flexible ear, nose, and throat endoscopes, flexible urology endoscopes, and other types of reusable flexible endoscopes used in procedural and surgical settings, and semi-rigid operative endoscopes (e.g., choledochoscopes) used in health care facilities. These guidelines are intended to provide comprehensive information and direction for health care personnel in the processing of these reusable devices and accessories to render them safe for patient use.

    دانلود استاندارد پردازش آندوسکوپ انعطاف‌پذیر و نیمه‌سخت در مراکز درمانی

    دستورالعمل‌هایی را برای نحوه‌ی استفاده، حمل و نقل، آزمایش نشت (در صورت لزوم)، تمیز کردن، بسته‌بندی (در صورت لزوم)، ضدعفونی و/یا استریل کردن سطح بالا، نگهداری و روش‌های کنترل کیفیت آندوسکوپ‌های انعطاف‌پذیر دستگاه گوارش (GI)، برونکوسکوپ‌های انعطاف‌پذیر، آندوسکوپ‌های انعطاف‌پذیر گوش، بینی و گلو، آندوسکوپ‌های انعطاف‌پذیر اورولوژی و سایر انواع آندوسکوپ‌های انعطاف‌پذیر قابل استفاده مجدد مورد استفاده در محیط‌های رویه‌ای و جراحی و آندوسکوپ‌های نیمه سخت جراحی (به عنوان مثال، کولدوکوسکوپ) مورد استفاده در مراکز مراقبت‌های بهداشتی ارائه می‌دهد. این دستورالعمل‌ها با هدف ارائه اطلاعات و راهنمایی جامع برای پرسنل مراقبت‌های بهداشتی در پردازش این دستگاه‌ها و لوازم جانبی قابل استفاده مجدد به منظور ایمن‌سازی آنها برای استفاده بیمار تدوین شده‌اند.

  • دانلود کتاب ISRAEL’S DIVINE MISSION AGAINST IRAN: How Meticulously Israel Plans To Break Iran’s Ayatollah’s Neck

    دانلود کتاب ISRAEL’S DIVINE MISSION AGAINST IRAN: How Meticulously Israel Plans To Break Iran’s Ayatollah’s Neck

    خرید ایبوک ISRAEL’S DIVINE MISSION AGAINST IRAN

    برای دانلود ایبوک ISRAEL’S DIVINE MISSION AGAINST IRAN: How Meticulously Israel Plans To Break Iran’s Ayatollah’s Neck و خرید کتاب ماموریت الهی اسرائیل علیه ایران: اسرائیل چقدر دقیق برای شکستن گردن ایران برنامه‌ریزی می‌کند بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود کتاب ایمیل می شود.این ایبوک در فرمت Epub به همراه PDF تبدیلی و به زبان انگلیسی ارسال می شود.نسخه الکترونیکی کتاب قابلیت کپی برداری copy و Paste دارد.

    در صورتی که نیاز به پی دی اف هر کتابی از انتشارات HarperCollins Leadership دارید با گیگاپیپر مکاتبه کنید.

    ISRAEL’S DIVINE MISSION AGAINST IRAN: How Meticulously Israel Plans To Break Iran’s Ayatollah’s Neck

    by Aaron Bernstein (Author)

    Publication date ‏ : ‎ March 7, 2025

    Language ‏ : ‎ English

    ASIN ‏ : ‎ B0DZTPWQSH

    Send email to download :ایمیل گیگاپیپر دانلود کتاب مقاله پایان نامه

    Price : 9$

    https://www.amazon.com/ISRAELS-DIVINE-MISSION-AGAINST-IRAN-ebook/dp/B0DZTPWQSH
    https://www.amazon.com/dp/B0DZTPWQSH

    دانلود رایگان کتاب ISRAEL’S DIVINE MISSION AGAINST IRAN

    Benjamin Netanyahu, Israel’s longest-serving prime minister, emerged from the ashes of the October 7 Hamas massacre with a singular, unyielding vision: to reshape the Middle East’s geopolitical landscape by eradicating the Iranian axis of terror and ensuring Israel’s unchallenged security dominance. The catastrophic intelligence and military failures of that day, which saw over 1,200 Israelis slaughtered and hundreds taken hostage, became a catalyst for Netanyahu to recalibrate his strategy, pivoting from containment to annihilation of threats. Central to his post-October 7 doctrine is the belief that Israel cannot coexist with a nuclear-capable Iran or its proxies – Hezbollah, Hamas, and the Houthis – and that the Jewish state must act unilaterally, if necessary, to dismantle Tehran’s ring of fire. Netanyahu’s plan hinges on a three-pronged approach: decimating Hamas in Gaza to restore deterrence, forging unprecedented regional alliances with Sunni Arab states under the banner of countering Iran, and preparing for a potential preemptive strike against Iran’s nuclear infrastructure. His government has accelerated defense partnerships, including integrating a U.S.-led Middle East NATO-style air defense network into Israel’s defense structure and expanding covert operations targeting Iranian nuclear scientists, missile engineers, and Revolutionary Guard commanders.

    دانلود ایبوک ماموریت الهی اسرائیل علیه ایران: اسرائیل چقدر دقیق برای شکستن گردن ایران برنامه‌ریزی می‌کند

    بنیامین نتانیاهو، طولانی‌ترین نخست وزیر اسرائیل، از خاکستر قتل عام حماس در ۷ اکتبر با یک دیدگاه منحصر به فرد و تسلیم ناپذیر ظهور کرد: تغییر شکل چشم‌انداز ژئوپلیتیکی خاورمیانه با ریشه کن کردن محور ترور ایران و تضمین تسلط امنیتی بلامنازع اسرائیل. شکست‌های فاجعه‌بار اطلاعاتی و نظامی آن روز، که منجر به قتل بیش از ۱۲۰۰ اسرائیلی و گروگان گرفته شدن صدها نفر شد، به عاملی برای نتانیاهو تبدیل شد تا استراتژی خود را از نو تنظیم کند و از مهار به نابودی تهدیدها تغییر جهت دهد. دکترین پس از ۷ اکتبر او بر این باور استوار است که اسرائیل نمی‌تواند با ایران دارای توانایی هسته‌ای یا نیروهای نیابتی آن – حزب‌الله، حماس و حوثی‌ها – همزیستی داشته باشد و دولت یهود باید در صورت لزوم به صورت یکجانبه برای از بین بردن حلقه آتش تهران اقدام کند. طرح نتانیاهو بر یک رویکرد سه‌جانبه استوار است: نابودی حماس در غزه برای بازگرداندن بازدارندگی، ایجاد اتحادهای منطقه‌ای بی‌سابقه با کشورهای عرب سنی تحت عنوان مقابله با ایران، و آماده شدن برای یک حمله پیشگیرانه بالقوه علیه زیرساخت‌های هسته‌ای ایران. دولت او همکاری‌های دفاعی را تسریع کرده است، از جمله ادغام یک شبکه دفاع هوایی به سبک ناتوی خاورمیانه به رهبری ایالات متحده در ساختار دفاعی اسرائیل و گسترش عملیات مخفی با هدف قرار دادن دانشمندان هسته‌ای، مهندسان موشکی و فرماندهان سپاه پاسداران ایران.

    Mossad . . . . . . . . . . . . . . . . . . . . . . . . . . 20
    Unit 8200 and AI Deep Defense . . . . . . . . . . . . . . 36
    Satellite Reconnaissance . . . . . . . . . . . . . . . . . . 51
    US Cooperation . . . . . . . . . . . . . . . . . . . . . . 59
    Israel’s Support for Separatists Groups . . . . . . . . . . . 63
    Air Operations67
    The F-35: Technical Examination and Operational Roles . 70
    Stealth Technology . . . . . . . . . . . . . . . . . . . . 75
    Air-Launched Ballistic Missiles . . . . . . . . . . . . . . 81
    Stealth Cruise Missiles . . . . . . . . . . . . . . . . . . . 84
    Drones . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
    Precision-Guided Munitions . . . . . . . . . . . . . . . 92
    Aerial Refueling . . . . . . . . . . . . . . . . . . . . . . 95
    Cyber and Electronic Operations97
    Cyber Attacks . . . . . . . . . . . . . . . . . . . . . . . 100Electronic Warfare . . . . . . . .
    . . . . . . . . . . . . . 109ii
    Defending against Iran’s retaliation113Israel’s Nuclear Weapons 122Comprehensive Israeli Attack Plan on Iran: A Detailed Scenario127Cautious to High Risk Scenarios140Geopolitical Implications and Conclusion157Appendices161Techical Details 162
    Logic Bomb . . . . . . . . . . . . . . . . . . . . . . . . 162
    Quantum Insert . . . . . . . . . . . . . . . . . . . . . . 164
    Bermuda Malware . . . . . . . . . . . . . . . . . . . . . 168
    Suter . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
    Gray Matter AI algorithms . . . . . . . . . . . . . . . . 175
    The Golden Almond Command and Control System . . . 177
    Russian Su-35 Delivery to Iran: A Cause for Concern? . . . 180
    Carbon Bombs . . . . . . . . . . . . . . . . . . . . . . . 184
    Jericho III . . . . . . . . . . . . . . . . . . . . . . . . . 187
    The Breakout Clock: Iran’s Nuclear Timeline . . . . . . . 189
    Multi-Point Initiation . . . . . . . . . . . . . . . . . . . 192
    Bibliography199About the Author207

  • دانلود کتاب Utilizing AI and Machine Learning for Natural Disaster Management

    دانلود کتاب Utilizing AI and Machine Learning for Natural Disaster Management

    خرید ایبوک Utilizing AI and Machine Learning for Natural Disaster Management

    برای دانلود ایبوک Utilizing AI and Machine Learning for Natural Disaster Management و خرید کتاب استفاده از هوش مصنوعی و یادگیری ماشینی برای مدیریت بلایای طبیعی بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود کتاب ایمیل می شود.این ایبوک در فرمت PDF اورجینال و به زبان انگلیسی ارسال می شود.نسخه الکترونیکی کتاب قابلیت کپی برداری copy و Paste دارد.

    Utilizing AI and Machine Learning for Natural Disaster Management

    by D Satishkumar (Editor), M Sivaraja (Editor)

    Publisher ‏ : ‎ IGI Global (April 29, 2024)

    Language ‏ : ‎ English

    Paperback ‏ : ‎ 380 pages

    ISBN-13 ‏ : ‎ 979-8369348277

    Send email to download :ایمیل گیگاپیپر دانلود کتاب مقاله پایان نامه

    Price : 25$

    www.amazon.com/Utilizing-Machine-Learning-Disaster-Management/dp/B0D33VZRHS/

    دانلود رایگان کتاب استفاده از هوش مصنوعی و یادگیری ماشینی برای مدیریت بلایای طبیعی

    www.amazon.com/Utilizing-Machine-Learning-Disaster-Management/dp/B0D33VZRHS/

    Acute events of natural origin, spanning atmospheric, biological, geophysical, hydrologic, and oceanographic realms, persistently menace societies globally. Approximately 160 million people annually bear the brunt of these disasters, with certain regions facing disproportionate impacts. The lack of predictability intensifies the challenge, creating intercommunal capacity gaps and amplifying the dire consequences. Utilizing AI and Machine Learning for Natural Disaster Management provides instances of ML in predicting earthquakes. By leveraging seismic data, AI systems can analyze magnitude and patterns, providing invaluable insights to forecast earthquake occurrences and aftershocks. Similarly, the book unveils the potential of ML in simulating floods by recording and analyzing rainfall patterns from previous years. The predictive power extends to hurricanes, where data on wind speed, rainfall, temperature, and moisture converge to anticipate future occurrences, potentially saving millions in property damage.

    قیمت و خرید دانلود کتاب Utilizing AI and Machine Learning for Natural Disaster Management

    رویدادهای حاد با منشأ طبیعی، که حوزه‌های جوی، بیولوژیکی، ژئوفیزیکی، هیدرولوژیکی و اقیانوس‌شناسی را در بر می‌گیرد، به طور مداوم جوامع جهانی را تهدید می‌کند. تقریباً ۱۶۰ میلیون نفر سالانه متحمل بار این بلایا می‌شوند و مناطق خاصی با تأثیرات نامتناسبی روبرو هستند. عدم پیش‌بینی‌پذیری، این چالش را تشدید می‌کند، شکاف‌های ظرفیت بین جوامع ایجاد می‌کند و عواقب وخیم را تشدید می‌کند. استفاده از هوش مصنوعی و یادگیری ماشینی برای مدیریت بلایای طبیعی، نمونه‌هایی از یادگیری ماشینی را در پیش‌بینی زلزله ارائه می‌دهد. با استفاده از داده‌های لرزه‌ای، سیستم‌های هوش مصنوعی می‌توانند بزرگی و الگوها را تجزیه و تحلیل کنند و بینش‌های ارزشمندی را برای پیش‌بینی وقوع زلزله و پس‌لرزه‌ها ارائه دهند. به طور مشابه، این کتاب با ثبت و تجزیه و تحلیل الگوهای بارندگی از سال‌های گذشته، پتانسیل یادگیری ماشینی را در شبیه‌سازی سیل آشکار می‌کند. قدرت پیش‌بینی به طوفان‌ها نیز گسترش می‌یابد، جایی که داده‌های مربوط به سرعت باد، بارندگی، دما و رطوبت برای پیش‌بینی وقوع آینده همگرا می‌شوند و به طور بالقوه میلیون‌ها نفر را در خسارت به اموال نجات می‌دهند.

    Preface……………………………………………………………………………………………………………………………….. xx
    Acknowledgment……………………………………………………………………………………………………………..xxvii
    Introduction……………………………………………………………………………………………………………………xxviii
    Chapter 1
    UtilizingAIandMachineLearningforNaturalDisasterManagement:OverviewofMachine
    LearningandItsImportanceinDisasterManagement………………………………………………………………… 1
    Divya S. V., V.S.B. College of Engineering Technical Campus, Coimbatore, India
    Venkadesh P., V.S.B. College of Engineering Technical Campus, Coimbatore, India
    Yazhini S., V.S.B. College of Engineering Technical Campus, Coimbatore, India
    Shiny K. V., Bharath Institute of Higher Education and Research, Chennai, India
    Chapter 2
    MachineLearningAlgorithmsforNaturalDisasterPredictionandManagement…………………………. 24
    Shanthalakshmi Revathy J., Velammal College of Engineering and Technology, India
    Mangaiyarkkarasi J., NMSS Vellaichamy Nadar College, India
    Chapter 3
    PredictingNaturalDisastersWithAIandMachineLearning…………………………………………………….. 39
    P Venkadesh, V.S.B. College of Engineering Technical Campus, Coimbatore, India
    Divya S. V., V.S.B. College of Engineering Technical Campus, Coimbatore, India
    P Marymariyal, V.S.B. College of Engineering Technical Campus, Coimbatore, India
    S. Keerthana, V.S.B. College of Engineering Technical Campus, Coimbatore, India
    Chapter 4
    PredictiveAnalysisofMachineLearningAlgorithmsApplicableforNaturalDisaster
    Management………………………………………………………………………………………………………………………… 65
    Nagarani N., Velammal College of Engineering and Technology, India
    Ramji T. B., Velammal College of Engineering and Technology, India
    Kishorelal A, R., Velammal College of Engineering and Technology, India
    
    Chapter 5
    ANNModelforPredictingtheNaturalDisaster:Data-DrivenApproachesforNaturalDisaster
    PredictionandMitigation……………………………………………………………………………………………………… 80
    Gobinath A., Velammal College of Engineering and Technology, India
    Rajeswari P., Velammal College of Engineering and Technology, India
    Anandan M., Velammal College of Engineering and Technology, India
    Suresh Kumar N., Velammal College of Engineering and Technology, India
    Chapter 6
    PredictingRainfallbyFuzzyLogic:APreliminaryAnalysisofaCaseStudyinMexico………………. 99
    Jaime Santos-Reyes, SEPI-ESIME, ZAC, Instituto Politecnico Nacional, Mexico
    Yunue Garcia-Pimentel, Instituto Politécnico Nacional, Mexico
    Chapter 7
    AComprehensiveInvestigationofUnderwaterDisasterPredictionUsingMachineLearning
    Algorithms………………………………………………………………………………………………………………………… 118
    Nivethitha R., Velammal College of Engineering and Technology, India
    Sivasankari Jothiraj, Velammal College of Engineering and Technology, India
    Divya Bharathi P., KLN College of Engineering and Technology, India
    Sathish Kumar D., Nehru Institute of Technology, India
    Chapter 8
    PredictionofEarthquakes,VolcanicEruptions,Tornadoes,Wildfires,andDroughtsThrough
    ArtificialIntelligence………………………………………………………………………………………………………….. 133
    Selvakumar P., Nehru Institute of Technology, India
    Vijayakumar G., Vivekanandha College of Engineering for Women, India
    Vigneshkumar P., KGiSL Institute of Technology, India
    Umamaheswari M. S., Nehru Institute of Technology, India
    Selvamurugan C., Dhaanish Ahmed Institute of Technology, India
    Satheesh kumar P., Dr. N.G.P. Institute of Technology, India
    Chapter 9
    MachineLearningModelsforPredictionofLandslidesintheHimalayas…………………………………. 146
    Vikram Singh, Ch. Devi Lal University, Sirsa, India
    Sanjay Tyagi, Kurukshetra University, India
    Chapter 10
    WearableSensorandAIAlgorithmIntegrationforEnhancedNaturalDisasterPreparednessand
    Response…………………………………………………………………………………………………………………………… 175
    Gobinath A., Velammal College of Engineering and Technology, India
    Rajeswari P., Velammal College of Engineering and Technology, India
    Suresh Kumar N., Velammal College of Engineering and Technology, India
    Anandan M., Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology,
    India
    
    Chapter 11
    ANovelApproachonIoT-BasedNaturalDisasterPredictionandEarlyWarningSystems(EWS).. 189
    Karthikeyan Pathinettampadian, Anna University, India & Velammal College of Engineering
    and Technology, India
    Nagarani N., Velammal College of Engineering and Technology, India
    Shivani Suvatheka S., Velammal College of Engineering and Technology, India
    Al Mohamed Bilal A., Velammal College of Engineering and Technology, India
    Chapter 12
    UnleashingMachineWisdom:AGlimpseIntoAI-PoweredTsunamiEarlyWarningSystems…….. 208
    Siddique Ibrahim S. P., VIT-AP University, India
    Ireddi Rakshitha, VIT-AP University, India
    Uppara Nithin, VIT-AP University, India
    Lakkakula Namratha, VIT-AP University, India
    Naga Sai Rahul V., VIT-AP University, India
    Mohammed Abdul Kareem Shaik, VIT-AP University, India
    Chapter 13
    DisasterandItsImpactonCerebralHealth:MethodologyandPsychologicalEffectsofDisaster…. 227
    K. Parimala Gandhi, Nehru Institute of Technology, India
    K. Janani, Nehru Institute of Technology, India
    Sivaraja M., Nehru Institute of Technology, India
    Gomathi P., Study World College of Engineering, India
    satishkumar D., Nehru Institute of Technology, India
    Chapter 14
    AIandMachineLearningAlgorithm-BasedSolutionsforComplicationsinNaturalDisaster……… 237
    Sathya D., RV University, India
    Siddique Ibrahim S. P., VIT-AP University, India
    Jagadeesan D., Kaamadhenu Arts and Science College, India
    Chapter 15
    PredictingNaturalDisastersWithAIandMachineLearning…………………………………………………… 254
    Manjula Devi C., Velammal College of Engineering and Technology, India
    Gobinath A., Velammal College of Engineering and Technology, India
    Padma Priya S., PSNA College of Engineering and Technology, India
    Reshmika K. S., Velammal College of Engineering and Technology, India
    Sivakarthi G., Velammal College of Engineering and Technology, India
    Chapter 16
    DeepLearningandAI-PoweredNaturalCatastrophesWarningSystems…………………………………… 274
    Siddique Ibrahim S. P., VIT-AP University, India
    Sathya D., RV University, India
    Gokulnath B. V., VIT-AP University, India
    Selva kumar S., VIT-AP University, India
    Jai Singh W., Presidency University, India
    Thangavel Murugan, United Arab Emirates University, UAE
    
    Chapter 17
    MachineLearning-BasedSeismicActivityPrediction…………………………………………………………….. 293
    Ajai V., Velammal College of Engineering and Technology, India
    S. Gandhimathi alias Usha, Velammal College of Engineering and Technology, India
    B. D. S. Suntosh, Velammal College of Engineering and Technology, India
    M. Muthukumar, Velammal College of Engineering and Technology, India
    K. Manoj Raj, Velammal College of Engineering and Technology, India
    V. Suriyanarayanan, Velammal College of Engineering and Technology, India
    Compilation of References………………………………………………………………………………………………… 307
    About the Contributors…………………………………………………………………………………………………….. 335
    Index………………………………………………………………………………………………………………………………… 338

  • دانلود استاندارد GRTCA DO-160 خرید استاندارد Environmental Conditions and Test Procedures for Airborne Equipment

    دانلود استاندارد GRTCA DO-160 خرید استاندارد Environmental Conditions and Test Procedures for Airborne Equipment

    خرید استاندارد RTCA DO-160G

    برای دانلود استاندارد RTCA DO-160G و خرید استاندارد Environmental Conditions and Test Procedures for Airborne Equipment سال 2014 و 542 صفحه بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت و تکمیل مراحل خرید، لینک دانلود ایمیل می شود. این استاندارد در فرمت PDF ارسال می شود. توجه کنید که نسخه استاندارد 2014 می باشد.

    کلیه استانداردهای RTCA موسسه کميته فني راديو هوانوردي موجود است. برای دریافت PDF استاندارد  Radio Technical Commission for Aeronautics، شماره استاندارد مورد نظر را برای ما ارسال کنید.

    در صورتی که نیاز به دانلود هر استانداردی از IHS و یا techstreet دارید، فقط کافیست ادرس اینترنتی استاندارد را از سایت http://techstreet.com  و یا https://global.ihs.com برای ما ارسال کنید (راههای ارتباطی در صفحه تماس با گیگاپیپر ). پس از بررسی، هزینه ان اعلام می شود. پس از واریز نسخه الکترونیکی ارسال می شود.

    دانلود استاندارد RTCA خرید استاندارد Radio Technical Commission for Aeronautics
    دانلود استاندارد RTCA خرید استاندارد Radio Technical Commission for Aeronautics

    RTCA DO-160G

    Environmental Conditions and Test Procedures for Airborne Equipment
    STANDARD by Radio Technical Commission for Aeronautics, 2014

    لینک استاندارد RTCA DO-254:

    For Download Please Contact Us :ایمیل گیگاپیپر دانلود کتاب مقاله پایان نامه
    Price : 50$

    دانلود رایگان استاندارد RTCA DO-160 سال 2000

    برای اطمینان از کیفیت استاندارد RTCA DO 160، چند صفحه ابتدایی ان بصورت رایگان قرار داده شده است.

    RTCA, Inc.
    1828 L Street, NW Suite 805
    Washington, DC 20036
    RTCA/DO-160G
    Environmental Conditions and Test
    Procedures for Airborne Equipment
    Section 1
    Purpose and Applicability
    Section 2
    Definitions of Terms
    Section 3
    Conditions of Tests

    درباره استاندارد RTCA DO-160G

    Published: 2014

    Number of Pages:542

    فهرست مطالب استاندارد RTCA DO-160 سال 2014

    Table of Contents ………………………………………………………………………………………………………………………. iii
    Section 1.0
    Purpose and Applicability
    Section 2.0
    Definitions of Terms – General
    Section 3.0
    Conditions of Tests
    Section 4.0
    Temperature and Altitude
    Section 5.0
    Temperature Variation
    Section 6.0
    Humidity
    Section 7.0
    Operational Shocks and Crash Safety
    Section 8.0
    Vibration
    Section 9.0
    Explosion Proofness
    Section 10.0
    Waterproofness
    Section 11.0
    Fluids Susceptibility
    Section 12.0
    Sand and Dust
    Section 13.0
    Fungus Resistance
    Section 14.0
    Salt Spray
    Section 15.0
    Magnetic Effect
    Section 16.0
    Power Input
    Section 17.0
    Voltage Spike
    Section 18.0
    Audio Frequency Conducted Susceptibility – Power Inputs
    Section 19.0
    Induced Signal Susceptibility
    Section 20.0
    Radio Frequency Susceptibility (Radiated and Conducted)
    Section 21.0
    Emission of Radio Frequency Energy
    Section 22.0
    Lightning Induced Transient Susceptibility
    Section 23.0
    Lightning Direct Effects
    Section 24.0
    Icing
    Section 25.0
    Electrostatic Discharge
    Section 26.0
    Fire, Flammability
    Appendix A
    Environmental Test Identification
    Appendix B
    Membership
    Appendix C
    Change Coordinators
    Note:
    Detailed Tables of Contents appear on the inside of most sections.

    توضیحات شرایط محیطی و رویه‌های آزمایش تجهیزات هوابرد (همچنین به ضمیمه RTCA DO-357 برای RTCA DO-160G مراجعه کنید)

    Purpose and Applicability
    This document defines a series of minimum standard environmental test conditions
    (categories) and applicable test procedures for airborne equipment. The purpose of these
    tests is to provide a laboratory means of determining the performance characteristics of
    airborne equipment in environmental conditions representative of those which may be
    encountered in airborne operation of the equipment.
    The standard environmental test conditions and test procedures contained herein may be
    used in conjunction with applicable equipment performance standards as a minimum
    specification under environmental conditions, which can ensure a sufficient degree of
    confidence in performance during operations.
    Note:
    In each of the test procedures contained herein, the following phrase will
    be seen several times:
    DETERMINE COMPLIANCE WITH APPLICABLE EQUIPMENT
    PERFORMANCE STANDARDS.
    The “applicable equipment performance standards” referred to are either:
    a.
    EUROCAE Minimum Operational Performance Specifications
    (formerly Requirements) (MOPS/MOPR).
    b.
    RTCA Minimum Performance Standards (MPS) and/or RTCA
    Minimum Operational Performance Standards (MOPS).
    c.
    The manufacturers equipment specification(s), where applicable.
    Some of the environmental conditions and test procedures contained in this document are
    not necessarily applicable to all airborne equipment. The selection of the appropriate
    and/or additional environmental conditions and test procedures is the responsibility of the
    writers (authors) of the performance standards for the specific airborne equipment.
    Notes:
    1.
    There are several additional environmental conditions (categories), that specific
    airborne equipment may need to be evaluated against, that have not been included
    in this document. These include, but are not limited to: hail, acceleration and
    acoustic vibration.
    2.
    The procedures for testing airborne equipment for special environmental
    conditions that are usually uniquely related to that specific type of airborne
    equipment, should be the responsibility of the writer (author) of the performance
    standard for that specific equipment.
    Copyright RTCA, Inc.
    Provided by IHS under license with RTCA, Inc.
    Licensee=BAE Birtley, Glascoed/5932949024, User=sam, albett
    Not for Resale, 03/21/2016 06:55:50 MDT
    No reproduction or networking permitted without license from IHS
    –“,`,“,`,“,“,,,`,,,,`,`,,`,-`-`,,`,,`,`,,`—
    info@GigaPaper.ir
    1-2
    © 2010 RTCA, Inc.
    3.
    The International System of Units (SI) is usually used throughout this document
    as the primary values. In certain instances, however, when the primary values
    were derived in US units, these units are used as the primary values.
    4.
    Subject to the provisions of Subsection 3.2, it is permissible to use more than one
    test article.
    The words airborne equipment, as used within this document, have direct applicability to
    most airborne equipment. It is the responsibility of those who wish to apply the test
    conditions and procedures contained in this document to determine the applicability of
    these test conditions and procedures to a specific equipment intended for installation on,
    or within, a specific or general class or type of aircraft.
    Minimum operational performance standards (MOPS) prepared by RTCA, Inc. for
    airborne equipment contain requirements that the equipment must meet to ensure reliable
    operation in actual aeronautical installations. These equipment requirements must be
    verified in ambient and stressed environmental conditions. The MOPS typically contain
    recommended bench test procedures for ambient conditions, and refer to RTCA Document
    DO-160, “Environmental Conditions and Test Procedures for Airborne Equipment,” for
    the stressed environmental testing. The test categories defined in DO-160 are intended to
    encompass the full spectrum of environmental conditions that airborne equipment may
    experience – from benign to very hostile.
    The environmental conditions and test procedures defined herein are intended to
    determine only the performance of the airborne equipment under these environmental
    conditions and are not intended to be used as a measure of service life of the airborne
    equipment subjected to these tests.
    Any regulatory application of this document is the sole responsibility of appropriate
    governmental (regulatory) agencies.
    1.1
    Historical Note, and General Guidance to Users
    DO-160 (or its precursor, DO-138) has been used as a standard for environmental
    qualification testing since 1958. It has been referenced in Minimum Operational
    Performance Specifications (MOPS) for specific equipment designs, and is referenced in
    FAA Advisory Circulars as a means of environmental qualification for TSO authorization.
    It has been subject to a continuous process of upgrade and revision as new needs arose
    within the aviation community, as improved test techniques have emerged, and as the
    realities of equipment operation of under actual environmental conditions has become
    better understood.
    Environmental stresses can result from natural forces or man made effects, and may be
    mitigated by details of the equipment installation. The categories that have been
    Copyright RTCA, Inc.
    Provided by IHS under license with RTCA, Inc.
    Licensee=BAE Birtley, Glascoed/5932949024, User=sam, albett
    Not for Resale, 03/21/2016 06:55:50 MDT
    No reproduction or networking permitted without license from IHS
    –“,`,“,`,“,“,,,`,,,,`,`,,`,-`-`,,`,,`,`,,`—
    info@GigaPaper.ir
    1-3
    © 2010 RTCA, Inc.
    developed over time reflect a reasonably mature understanding as to the severity of the
    stresses, the degrees of mitigation achievable in the design of an installation, and the
    robustness that must be designed into equipment in order to perform under the resultant
    stress. In order to fully reap the advantages of the maturity of this document, it is
    incumbent upon the designers of the installed equipment, as well as the designers of the
    host installation, to consider the categories defined herein as early in their programs as
    feasible. The categories defined within each environmental test procedure have proved to
    be a practical set of boundary conditions between the requirements of real world
    installations and the performance of installed equipment. Effective dialogue between the
    airframe and equipment designers is essential to ensure that correct categories are utilized.

  • دانلود کتاب ISPE Guide: 503A Compounding Regulatory Basis and Industry Good Practices for Pharmacies

    دانلود کتاب ISPE Guide: 503A Compounding Regulatory Basis and Industry Good Practices for Pharmacies

    خرید ایبوک Guide: 503A Compounding

    برای دانلود ایبوک ISPE Guide: 503A Compounding – Regulatory Basis and Industry Good Practices for Pharmacies و خرید کتاب راهنمای ISPE: ترکیب 503A – مبانی نظارتی و شیوه‌های خوب صنعت برای داروخانه‌ها 2024 بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود کتاب ایمیل می شود.این ایبوک در فرمت PDF اورجینال و به زبان انگلیسی ارسال می شود.نسخه الکترونیکی کتاب قابلیت کپی برداری copy و Paste دارد.

    در صورتی که نیاز به پی دی اف هر کتابی از انتشارات International Society for Pharmaceutical Engineering (ISPE) دارید با گیگاپیپر مکاتبه کنید.

    خرید کتاب ISPE Guide: 503A Compounding

    ISPE Guide: 503A Compounding – Regulatory Basis and Industry Good Practices for Pharmacies

    Handbook / Manual / Guide by International Society for Pharmaceutical

    Engineering , 2024 by ISPE

    Pages: 72

    Published: 2024

    Send email to download :ایمیل گیگاپیپر دانلود کتاب مقاله پایان نامه

    Price : 55$

    https://store.accuristech.com/standards/ispe-guide-503a-compounding-regulatory-basis-and-industry-good-practices-for-pharmacies?product_id=2905722
    
    https://ispe.org/publications/guidance-documents/guide-503a-compounding

    دانلود رایگان کتاب ISPE Guide: 503A Compounding 2024

    Following the need identified by the ISPE survey of compounding pharmacies and regulators, it is evident that compounding pharmacies would benefit from consolidating FDA regulations and recommendations and the United States Pharmacopeia (USP) criteria into a single guide.

    The ISPE Guide: 503A Compounding – Regulatory Basis and Industry Good Practices for Pharmacies provides an overview of FDA regulations and guidance necessary for conducting safe compounding to help pharmacies understand the requirements of FD&C Act Section 503A. In addition, the ISPE Guide outlines the authority of State Boards of Pharmacy and their coordination of oversight with the FDA.

    A significant portion of the Guide addresses USP Chapters <795>, <797>, <800>, and <1163>, which are critical for the operation of 503A pharmacies. The differences in USP <795> for nonsterile compounded preparations and USP <797> for sterile preparations are discussed throughout this ISPE Guide to aid 503A compounders in understanding the requirements and accessing appropriate information.

    Discussions include general compounding requirements for 503A pharmacies focusing on the Quality system and its application throughout the process from incoming materials and facilities and equipment, to storage, shipping, and transport. Readers will find the information on personnel knowledge and training requirements valuable. To aid pharmacies in maintaining compliance with federal and state regulations, several lists of suggested Standard Operating Procedures (SOPs) based on the type of compounding conducted are included.

    Although a high-level overview of the state board of pharmacy model is provided, the rules of the State Boards of Pharmacy and other equivalent state regulatory groups are considered out of scope, given the multitude of individual state regulations.

    دانلود ایبوک راهنمای ISPE: ترکیب 503A – مبانی نظارتی و شیوه‌های خوب صنعت برای داروخانه‌ها

    پیرو نیاز شناسایی‌شده توسط نظرسنجی ISPE از داروخانه‌های ترکیبی و تنظیم‌کنندگان، بدیهی است که داروخانه‌های ترکیبی از تجمیع مقررات و توصیه‌های FDA و معیارهای فارماکوپه ایالات متحده (USP) در یک راهنمای واحد بهره‌مند خواهند شد.

    راهنمای ISPE: 503A ترکیب – مبانی نظارتی و شیوه‌های خوب صنعت برای داروخانه‌ها، مروری بر مقررات و راهنمایی‌های FDA لازم برای انجام ترکیب ایمن ارائه می‌دهد تا به داروخانه‌ها کمک کند الزامات بخش 503A قانون FD&C را درک کنند. علاوه بر این، راهنمای ISPE اختیارات هیئت‌های ایالتی داروسازی و هماهنگی نظارت آنها با FDA را تشریح می‌کند.

    بخش قابل توجهی از این راهنما به فصل‌های USP <795>، <797>، <800> و <1163> می‌پردازد که برای عملکرد داروخانه‌های 503A بسیار مهم هستند. تفاوت‌های USP <795> برای فرآورده‌های ترکیبی غیراستریل و USP <797> برای فرآورده‌های استریل در سراسر این راهنمای ISPE مورد بحث قرار گرفته است تا به تولیدکنندگان فرآورده‌های 503A در درک الزامات و دسترسی به اطلاعات مناسب کمک کند.

    بحث‌ها شامل الزامات عمومی ترکیب برای داروخانه‌های 503A با تمرکز بر سیستم کیفیت و کاربرد آن در سراسر فرآیند از مواد و امکانات و تجهیزات ورودی گرفته تا ذخیره‌سازی، حمل و نقل و جابجایی است. خوانندگان اطلاعات مربوط به دانش پرسنل و الزامات آموزشی را ارزشمند خواهند یافت. برای کمک به داروخانه‌ها در رعایت مقررات فدرال و ایالتی، چندین فهرست از رویه‌های عملیاتی استاندارد (SOP) پیشنهادی بر اساس نوع ترکیب انجام شده گنجانده شده است.

    اگرچه یک مرور کلی سطح بالا از مدل هیئت داروسازی ایالتی ارائه شده است، اما با توجه به تعدد مقررات ایالتی، قوانین هیئت‌های داروسازی ایالتی و سایر گروه‌های نظارتی ایالتی معادل، خارج از محدوده در نظر گرفته می‌شوند.

    فهرست مطالب ISPE 503A Compounding – Regulatory Basis

    Table of Contents
    1
    Introduction ……………………………………………………………………………………………………….7
    1.1
    Background ………………………………………………………………………………………………………………………………..7
    1.2
    Current Situation …………………………………………………………………………………………………………………………7
    1.3
    Purpose ……………………………………………………………………………………………………………………………………..9
    1.4
    Scope ………………………………………………………………………………………………………………………………………..9
    2 503A Compounding Overview …………………………………………………………………………..11
    2.1
    Drugs Compounded under the FDA Compounding Quality Act, Section 503A [4] ………………………………. 11
    2.2
    FDA Insanitary Conditions ………………………………………………………………………………………………………….13
    2.3
    State Regulating Bodies …………………………………………………………………………………………………………….15
    2.4
    USP Chapters …………………………………………………………………………………………………………………………..16
    3 Types of Compounded Drugs/Preparations …………………………………………………….. 17
    3.1
    Nonsterile Compounded Drugs USP <795> [20] ……………………………………………………………………………17
    3.2
    Sterile Compounded Drugs USP <797> [21] …………………………………………………………………………………19
    4 General Compounding Requirements ……………………………………………………………… 23
    4.1
    Prescription Requirements………………………………………………………………………………………………………….23
    4.2
    Compounding Personnel USP <797> [21] …………………………………………………………………………………….23
    4.3
    Verification of Compounding Activities USP <1163> [29] …………………………………………………………………24
    4.4
    Pharmaceutical Dosage Forms USP <1151> [7] ……………………………………………………………………………25
    4.5
    Bulk Drug Substances ……………………………………………………………………………………………………………….25
    5 Quality Management System (QMS) ……………………………………………………………….. 27
    5.1
    SOPs ……………………………………………………………………………………………………………………………………….27
    5.2
    Documentation USP <1029> [7] ………………………………………………………………………………………………….28
    5.3
    MFR for Nonsterile and Sterile Compounding USP <795> [20] ………………………………………………………..29
    5.4
    ALCOA+ …………………………………………………………………………………………………………………………………..30
    5.5
    Additional Data Entry Practices …………………………………………………………………………………………………..30
    5.6
    Deviation/Incident Management System and Investigation/Out of Specification (OOS) Results/
    Notification of Recall of Dispensed CDPs ……………………………………………………………………………………..31
    5.7
    Safety/Patients USP <1163> [29] ………………………………………………………………………………………………..32
    5.8
    Safety Policy Recommendations …………………………………………………………………………………………………33
    5.9
    Audit Management System …………………………………………………………………………………………………………33
    5.10
    Chemical and Physical Stability …………………………………………………………………………………………………..33
    6 Training USP <797> [21] ………………………………………………………………………………….. 35
    7 Material Sourcing ……………………………………………………………………………………………. 39
    7.1
    Components Selection and Component Quality Evaluation USP <795> [20] ……………………………………..39
    7.2
    Receipt/Usage of Components USP <795> [20] ……………………………………………………………………………39
    7.3
    Component Quality Evaluation ……………………………………………………………………………………………………40
    For individual use only. © 2024 ISPE. All rights reserved.
    Page 6
    ISPE Guide:
    503A Compounding – Regulatory Basis and Industry Good Practices for Pharmacies
    8 Facilities and Equipment ………………………………………………………………………………….41
    8.1
    Facility ……………………………………………………………………………………………………………………………………..41
    8.2
    Air Exchange Requirements USP <797> [21] ………………………………………………………………………………..43
    8.3
    Water ………………………………………………………………………………………………………………………………………43
    8.4
    Equipment ………………………………………………………………………………………………………………………………..43
    8.5
    Equipment Verification USP <795> [20] ………………………………………………………………………………………..45
    9 Environmental Controls, Quality, and Maintenance …………………………………………. 47
    9.1
    Environmental Controls USP <797> [21] ………………………………………………………………………………………47
    9.2
    Environmental Monitoring (EM) USP <797> [21] ……………………………………………………………………………48
    9.3
    Cleaning, Disinfecting, and Maintenance of Environment USP <797> [21] ………………………………………..51
    9.4
    Cleaning, Disinfecting, and Safety ……………………………………………………………………………………………….52
    10 Testing USP <1163> [29] ………………………………………………………………………………….. 53
    10.1
    Testing Overview ……………………………………………………………………………………………………………………….53
    10.2
    Microbiological Testing USP <1163> [29] and <797> [21] ……………………………………………………………….53
    10.3
    Sterility Testing Conducted Using USP <71> …………………………………………………………………………………53
    10.4
    Endotoxin Testing Using USP <85> ……………………………………………………………………………………………..54
    10.5
    Antimicrobial Effectiveness Testing Using USP <51> ……………………………………………………………………..54
    10.6
    Microbial Limit Testing Using USP <61> or USP <62> ……………………………………………………………………54
    11 Compounded Drug Products – Handling, Storage, Shipping, and Transport …… 55
    11.1
    Packaging Requirements USP <659> [7] ……………………………………………………………………………………..55
    11.2
    Containers, Packaging, Repackaging, Labeling, and Storage………………………………………………………….55
    11.3
    Storage Requirements for Compounded Drugs……………………………………………………………………………..55
    11.4
    Labeling Procedures and Requirements……………………………………………………………………………………….56
    11.5
    Beyond-Use Date (BUD) USP <7> [7] and USP <1163> [29] …………………………………………………………..56
    11.6
    Measuring and Weighing ……………………………………………………………………………………………………………56
    11.7
    Shipping …………………………………………………………………………………………………………………………………..56
    11.8
    Recalling Dispensed Compounded Sterile Products USP <797> [21] ……………………………………………….57
    12 Appendix 1 – Suggested SOP Lists ………………………………………………………………….. 59
    12.1
    USP <1163> [29] ……………………………………………………………………………………………………………………….59
    12.2
    USP <795> [20] and USP <797> [21] …………………………………………………………………………………………..60
    12.3
    USP <800> [28] ………………………………………………………………………………………………………………………..61
    13 Appendix 2 – References ………………………………………………………………………………… 63
    14 Appendix 3 – Glossary (Acronyms and Abbreviations) …………………………………… 67